https://www.pharmaradar360.com hourly 1 https://www.pharmaradar360.com/news hourly 0.95 https://www.pharmaradar360.com/regulators daily 0.9 https://www.pharmaradar360.com/trials daily 0.85 https://www.pharmaradar360.com/pipeline daily 0.9 https://www.pharmaradar360.com/drug-approvals daily 0.9 https://www.pharmaradar360.com/journals weekly 0.8 https://www.pharmaradar360.com/pharma-companies weekly 0.8 https://www.pharmaradar360.com/specialties weekly 0.8 https://www.pharmaradar360.com/sources weekly 0.8 https://www.pharmaradar360.com/newsrooms weekly 0.8 https://www.pharmaradar360.com/pharma-tools weekly 0.8 https://www.pharmaradar360.com/pharma-communities weekly 0.75 https://www.pharmaradar360.com/pro weekly 0.75 https://www.pharmaradar360.com/tools weekly 0.7 https://www.pharmaradar360.com/about monthly 0.5 https://www.pharmaradar360.com/privacy yearly 0.35 https://www.pharmaradar360.com/support monthly 0.35 https://www.pharmaradar360.com/disclaimer yearly 0.35 https://www.pharmaradar360.com/drug/pembrolizumab daily 0.9 https://www.pharmaradar360.com/drug/semaglutide daily 0.9 https://www.pharmaradar360.com/drug/tirzepatide daily 0.9 https://www.pharmaradar360.com/drug/trastuzumab-deruxtecan daily 0.9 https://www.pharmaradar360.com/drug/osimertinib daily 0.9 https://www.pharmaradar360.com/drug/nivolumab daily 0.9 https://www.pharmaradar360.com/drug/dupilumab daily 0.9 https://www.pharmaradar360.com/drug/risankizumab daily 0.9 https://www.pharmaradar360.com/drug/lecanemab daily 0.9 https://www.pharmaradar360.com/drug/atezolizumab daily 0.9 https://www.pharmaradar360.com/article/pressure-cooker-pilot-destroys-pfas-in-sewage-but-scaling-up-is-a-challenge-e31e555c4cc81f97 2026-09-16T16:32:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-sucker-s-dilemma-the-psychology-of-getting-conned-e818af4adb86d4fd 2026-09-16T16:31:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/mamdani-s-consumer-cop-brings-lina-khan-s-playbook-to-nyc-5101674923b0f52e 2026-09-16T16:30:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-do-you-know-if-the-beef-you-re-buying-is-from-the-usa-adcafe36f1d419d1 2026-09-16T16:27:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/farmers-face-significant-head-winds-this-fall-harvest-thanks-to-high-fuel-costs-a2e3ddf655702b09 2026-09-16T16:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-soybeans-near-harvest-rain-and-disease-questions-remain-16f415c0d0633923 2026-09-16T16:24:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-ropes-in-123m-for-oral-thyroid-eye-disease-drug-545cdd139d817376 2026-09-16T15:57:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/heart-recipient-honours-organ-donors-with-transplant-games-overture-91018807af22fe2f 2026-09-16T15:50:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/gilead-reaches-hiv-prep-agreements-hong-kong-investigates-cloudbreak-ipo-9f9b09cdff1fc0b2 2026-09-16T15:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sicadi-resultados-de-categorizacion-de-docentes-investigadores-as-de-la-unlp-e34068010678089c 2026-09-16T15:36:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/raw-material-complexities-and-strategies-with-for-advanced-therapies-75982b30edb4c2d1 2026-09-16T15:33:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/legionellosis-in-residents-of-england-and-wales-2025-ddbdab6f2a833e23 2026-09-16T15:33:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/nasa-hubble-fellowship-program-2027-803e4575d6d906d0 2026-09-16T15:25:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-counting-sheep-to-forty-winks-three-tips-to-get-your-kids-back-on-a-healthy-a507f783ecee492d 2026-09-16T15:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cooking-class-livestream-italian-ground-turkey-frittata-d84cf9acb61ad274 2026-09-16T15:09:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-adrs-inched-up-as-telecom-and-biotech-led-472ac474aa915400 2026-09-16T15:08:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/cold-mortality-monitoring-report-england-winter-2024-to-2025-6966878552215588 2026-09-16T15:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/kibow-biotech-wins-2026-webaward-for-best-science-website-52d6a8ecf05d157c 2026-09-16T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mayer-brown-represents-underwriters-on-teva-pharmaceutical-s-us-4-9-billion-seni-3890078c3ce9091a 2026-09-16T14:58:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1s-what-is-behind-the-variation-in-efficacy-f2db9c17e19f1a25 2026-09-16T14:58:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/bauchaortenaneurysma-nach-evar-neue-wege-zur-besseren-nachsorge-fad268c1acffb4b9 2026-09-16T14:57:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/compras-y-contrataciones-ab71a6a5fe0835ec 2026-09-16T14:53:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-shortages-a426e4f99d62d81a 2026-09-16T14:50:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/law-firm-leader-to-chair-2026-long-island-heart-stroke-ball-ff797735c0b6f755 2026-09-16T14:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivre-avec-et-apres-un-cancer-les-promesses-et-les-defis-de-la-sante-numerique-945e8a65c5d7a4f3 2026-09-16T14:46:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/estates-safety-fund-initial-schemes-and-associated-funding-allocations-2026-to-2-578511fd55580096 2026-09-16T14:42:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-ends-als-program-after-phase-2-flop-adding-to-r-d-woes-da0b1c01b0e1cfd3 2026-09-16T14:28:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/buy-european-incentivising-eu-based-pharmaceutical-manufacturing-f0be7ec5d4a13c8d 2026-09-16T14:23:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-therapeutics-announces-first-patients-dosed-in-global-phase-3-orbit-pivota-493b66e4547da753 2026-09-16T14:12:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-names-novartis-veteran-ingrid-zhang-as-new-ceo-c36c83304cfb057b 2026-09-16T14:12:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/acrp-unveils-theme-for-2027-annual-conference-d04f966c0b3615d9 2026-09-16T14:09:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-an-immune-false-alarm-that-may-drive-rapid-aging-00104e3c1b86bb4e 2026-09-16T14:05:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/celebrating-what-holds-us-on-iphone-18-pro-f697be91e8bd515c 2026-09-16T13:59:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/carolina-housing-is-built-on-student-feedback-2c16247fc949a7a2 2026-09-16T13:58:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/eschback-launches-leader-standard-work-capability-in-seqonis-platform-d6bbb1809a7eb5ff 2026-09-16T13:54:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/collegium-pharmaceutical-at-h-c-wainwright-pushing-beyond-pain-by-investing-com-7acb87745e02bc6a 2026-09-16T13:45:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/arrowhead-achieves-clinical-validation-for-new-drug-platform-a8d024929ce7f48e 2026-09-16T13:39:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/sen-warren-demands-to-see-trump-drug-pricing-pharma-contracts-accuses-rfk-jr-of-b2c1b39832ead5db 2026-09-16T13:36:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/could-tracking-genetics-help-stop-myeloma-before-it-starts-371308d2ffb3b266 2026-09-16T13:31:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/10-ai-biotech-firms-in-northern-metropolis-to-get-early-cross-border-data-access-8d6ce46540846e4e 2026-09-16T13:31:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/heart-risks-provider-misconduct-and-a-21-year-old-s-6b7a9c26ed278664 2026-09-16T13:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-vaccination-information-for-healthcare-practitioners-2a8cecfc3a4c1e42 2026-09-16T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pre-submission-advice-support-for-innovative-medicines-b8e46373a16aa9af 2026-09-16T13:16:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-assessment-procedure-for-medicines-5034d11e20bd2b10 2026-09-16T13:15:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-pre-market-movers-meds-tpst-cupr-chart-the-course-b8cbe9650f92187b 2026-09-16T13:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicines-apply-for-a-variation-to-your-marketing-authorisation-bc0e2a85d91fcf38 2026-09-16T13:14:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pbm-entity-no-pharmaceutical-company-directly-contracted-with-15e0f87edc35ede0 2026-09-16T13:14:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/un-projet-de-recherche-pour-en-finir-avec-le-risque-de-noyade-des-personnes-lary-6ad6ce0ec9a9cf84 2026-09-16T13:13:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-nih-funding-crisis-that-could-reshape-biotech-for-years-to-come-b62b5f7bdd7a60de 2026-09-16T13:10:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-names-ex-novartis-exec-as-ceo-601341f40ad47d08 2026-09-16T13:10:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/calgary-based-biotech-founders-announced-as-recipients-of-canada-s-top-40-under-01c6c7755adde338 2026-09-16T13:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/naoko-takebe-md-phd-joins-wilmot-to-build-early-phase-clinical-trials-and-develo-7441cb8dd9acd00e 2026-09-16T13:08:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/sinphar-pharmaceutical-fy2026-h1-earnings-call-gross-margin-hits-record-45-4-aug-2c92cc8d92f59c34 2026-09-16T13:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notifiable-diseases-causative-agents-reports-for-2026-32900b46450305d4 2026-09-16T13:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-vaccine-5-years-and-over-pgd-and-vgd-6776102a716b3a92 2026-09-16T13:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-the-green-book-chapter-d276b249e49e4dc1 2026-09-16T13:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/finally-a-chance-to-breathe-christiana-gets-care-for-hirschsprung-s-disease-c3e13beb67f44b5a 2026-09-16T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-manufacturing-plant-setup-in-india-9388a1cfa87e6157 2026-09-16T12:54:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-the-whole-grain-sweet-spot-for-better-heart-health-74fe8c2892b5b3af 2026-09-16T12:52:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-concede-titulo-de-professora-emerita-a-ana-luiza-coelho-netto-07641e2218bdf689 2026-09-16T12:52:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncology-biotech-news-key-moves-to-watch-in-september-2026-78cb8609a164864f 2026-09-16T12:42:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-cuts-98-scottsdale-jobs-after-product-sale-02c12ed5bda7592e 2026-09-16T12:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-pays-sironax-125m-to-acquire-platform-for-crossing-the-blood-brain-barr-57efc9bfdd6fbe18 2026-09-16T12:32:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/ciclo-de-talleres-para-investigadores-de-la-unlp-2026-tercera-edicion-d1bb67ca66d66070 2026-09-16T12:31:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/looking-beyond-short-term-turmoil-syngene-is-investing-for-the-future-ff2542fffd1088f1 2026-09-16T12:29:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivosim-labs-unveils-new-namkindtm-drug-toxicity-data-at-eurotox-2026-demonstrat-7c307c64eb413c4e 2026-09-16T12:26:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/curiosity-guides-law-school-s-first-strait-fellow-1018a0e7604d6563 2026-09-16T12:26:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimi-health-opth-lines-up-phase-3-mdma-ptsd-trial-for-veterans-5e5dca7bb97f51cb 2026-09-16T12:25:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimi-health-expands-clinical-program-with-phase-3-trial-evaluating-mdma-assist-3138d9050b7df197 2026-09-16T12:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenetic-to-merge-with-santersus-ceding-85-of-combined-biotech-to-swiss-investors-38ce4de6437ed570 2026-09-16T12:21:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/guidance-covid-19-test-validation-approved-products-67c87baa13be15b5 2026-09-16T12:17:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/without-bacteria-or-chemicals-how-methanol-and-formaldehyde-form-abiotically-in-8f865ceb512ae516 2026-09-16T12:07:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/rezera-announces-plans-to-launch-the-reveal-pad-multi-center-study-investigating-8bbac5a19abb9435 2026-09-16T12:04:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/kendall-square-biotech-incubator-launches-program-to-draw-international-startups-e128c3dc2e07ddaa 2026-09-16T12:00:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/rolling-with-the-waves-ac90c33b7cf09730 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/women-s-experiences-accessing-health-information-online-trusted-sources-and-cont-1be2bf56f59deca5 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/platinum-naturals-easymulti-stress-men-affected-lots-incorrectly-labelled-for-vi-317c64c8990d36f5 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-banana-faces-an-existential-threat-can-biotech-save-it-6fa7858cd1651577 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-industry-accelerates-supply-chain-heat-decarbonization-e278b969d389bded 2026-09-16T11:51:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/professor-dr-jakob-nikolas-kather-wird-hopp-stiftungsprofessor-fur-kunstliche-in-8b53026d890c4691 2026-09-16T11:50:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-west-pharmaceutical-services-stock-outperforming-the-nasdaq-0f730f5a4482fb08 2026-09-16T11:50:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/globalpharma-and-princefarma-sign-mou-to-advance-pharmaceutical-distribution-in-e4c13edf0ce21061 2026-09-16T11:48:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-memoriam-rob-van-der-wal-8b01f45490929bc1 2026-09-16T11:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-announces-activation-of-university-of-florida-health-as-newe-84699260c629525c 2026-09-16T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ascendis-regains-obesity-rights-as-novo-exits-monthly-glp-1-deal-cf9dc0b84009e824 2026-09-16T11:27:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/opportunities-for-patients-and-the-public-to-be-involved-in-the-work-of-the-mhra-f3c0f65f319949e0 2026-09-16T11:27:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/europe-s-5bn-scaleup-fund-will-not-fix-biotech-s-funding-gap-even-its-backers-sa-4944433c0dc34ac8 2026-09-16T11:17:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/expres2ion-biotech-sek19-3m-to-13-guarantee-and-a-sek50m-equity-facility-5269a621b698e7d9 2026-09-16T11:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-therapeutics-announces-first-patients-dosed-in-global-phase-3-orbit-pivota-d75552e00382cd47 2026-09-16T11:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/guidance-national-patient-safety-alert-supporting-information-patient-hoists-and-481832dd1483a5a5 2026-09-16T11:04:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-patient-safety-alert-patient-hoists-and-slings-all-types-risk-of-death-96b745c6c3886211 2026-09-16T11:01:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/human-neurons-flourish-in-mouse-brains-offering-a-new-view-of-neurodevelopmental-ee7d34769d2e1775 2026-09-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-therapeutics-announces-123-million-series-c-financing-to-advance-phase-3-d-5cf553c7190d4864 2026-09-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-gets-123m-for-phase-3-trial-of-ex-astellas-drug-in-thyroid-eye-disease-3e28cc7677d34261 2026-09-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-laboratories-acquires-covetai-to-advance-veterinary-workflow-intelligence-81cfc6189054a50d 2026-09-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-de-la-actualizacion-de-la-informacion-de-seguridad-de-los-medic-9860b82efb555986 2026-09-16T10:59:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-announces-dividend-1d1e3cf8ca63c361 2026-09-16T10:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-recuerda-como-evitar-errores-de-medicacion-por-sobredosificacion-con-vi-e10c84f344062da2 2026-09-16T10:47:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/msd-7b118228b3a79e32 2026-09-16T10:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sclerodermia-humanitas-partecipa-alla-giornata-del-ciclamino-ef1b80297605f7c9 2026-09-16T10:42:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/six-neighbourhood-health-trailblazers-to-transform-care-e6da2526d470fa64 2026-09-16T10:41:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiedonhankinnan-tuokiot-syksylla-2026-2a2791a37b53bdb0 2026-09-16T10:31:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-announces-fda-clearance-for-ligasuretm-ras-maryland-instrument-on-the-adeda03ace33da07 2026-09-16T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/should-you-invest-in-the-vaneck-biotech-etf-bbh-03686cfedea3aa38 2026-09-16T10:20:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/ingrid-zhang-appointed-ceo-of-legend-biotech-amid-mid-september-2026-industry-le-5ed0fa87667a5ca9 2026-09-16T10:15:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/tv-drug-ads-could-lose-their-website-shortcut-for-risk-details-under-an-fda-rule-bc0a0495d16ec398 2026-09-16T10:15:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/9ad3c82bb027f830 2026-09-16T10:08:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-admet-ai-for-medicines-safety-stakeholder-survey-62ff7205a99e26f8 2026-09-16T10:08:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-warnt-vor-personalabbau-und-schlechterer-patientenversorgung-954f5acc34729d49 2026-09-16T10:07:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/8f0cd19707f1caf3 2026-09-16T10:06:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/775198a373c05713 2026-09-16T10:05:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/4644adfcfbaf2ab9 2026-09-16T10:03:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/ctt-pharma-corporate-updates-7cb9f05535b4eb81 2026-09-16T10:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/digitaler-zwilling-soll-brustkrebspravention-individueller-machen-65208fd48426370b 2026-09-16T09:54:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/ers-2026-obesity-an-independent-obstruction-to-biologic-treated-asthma-8fe9aca8139f27b2 2026-09-16T09:44:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/home-treatments-drive-smarter-sustainable-pharmaceutical-packaging-38172df7a6199e47 2026-09-16T09:36:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trials-for-medicines-good-clinical-practice-inspections-a1362df4adb5e02b 2026-09-16T09:36:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/reunion-del-comite-de-medicamentos-de-uso-humano-de-septiembre-de-2026-cf9a2cb6077912c0 2026-09-16T09:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-administration-shift-puts-this-corner-of-biotech-back-in-favor-9c761ffe135492bb 2026-09-16T09:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kim-yong-min-named-2026-jw-sungcheon-award-recipient-85a5f990849a0bc3 2026-09-16T09:27:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/daewoong-pharmaceutical-wins-2026-national-contribution-award-05149f7f49635776 2026-09-16T09:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kpbma-holds-korea-thailand-pharmaceutical-forum-in-bangkok-ec594cbe6f8df10b 2026-09-16T09:26:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/quotient-sciences-named-among-gen-s-10-cdmo-up-comers-2026-b8121582b4e6e4a1 2026-09-16T09:26:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-holds-public-hearing-on-psychedelic-drugs-as-trump-driven-push-gathers-pace-c37ed3be97b94076 2026-09-16T09:25:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-ai-is-reshaping-the-cdmo-sponsor-relationship-dbb6c49855c23d14 2026-09-16T09:10:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-we-underestimating-the-pharmaceutical-potential-of-the-cannabis-plant-579d1a341447e83f 2026-09-16T08:47:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/domestic-pharmaceutical-and-bio-stocks-which-are-considered-representative-growt-3fc642a021ab05a4 2026-09-16T08:47:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/korea-establishes-public-private-pharmaceutical-industry-innovation-council-647569a7800a757d 2026-09-16T08:44:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/helsinki-animal-law-seminar-xin-zheng-28-10-2026-b66334489694a403 2026-09-16T08:36:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/meddra-29-1-e37560fd41624dad 2026-09-16T08:33:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-ratios-at-birth-in-the-uk-2019-to-2023-e85b4ee4f5630c49 2026-09-16T08:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/migrant-health-country-of-origin-health-protection-advice-712e66654b02af33 2026-09-16T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-ratios-at-birth-in-the-uk-2018-to-2022-2e081caa376a5196 2026-09-16T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/sti-quarterly-surveillance-reports-provisional-data-24f79f77d1898abf 2026-09-16T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-clinical-research-delivery-key-performance-indicators-95d573354d6fb70d 2026-09-16T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-clinical-research-delivery-key-performance-indicators-data-to-august-2026-a91ff0b95960e676 2026-09-16T08:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/bovine-tuberculosis-tb-public-health-management-466209379572520b 2026-09-16T08:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/survey-into-the-radiological-impact-of-the-routine-transport-of-radiopharmaceuti-80b294175a4a0760 2026-09-16T08:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/excipient-selection-strategies-to-mitigate-nitrosamine-risks-812ded3585d60c32 2026-09-16T08:24:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/helsinki-animal-law-seminar-david-john-holroyd-17-9-2026-ea05ec76417c45c4 2026-09-16T08:22:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/toward-canonical-helm-representations-for-sequence-level-peptide-registration-d7409182dc2c1913 2026-09-16T08:18:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/9-25-jsmo-kfcr-408a09bcda0795e9 2026-09-16T08:09:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-system-enables-the-early-detection-of-drug-induced-liver-toxicities-in-pri-3a721253fe2bd48e 2026-09-16T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-biotech-corefx-chooses-cork-as-its-european-r-d-hq-718cbbd0532ecf2c 2026-09-16T07:55:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/wuxi-biologics-named-to-forbes-china-esg-50-list-2026-for-green-crdmo-and-digita-732f52b3717008fc 2026-09-16T07:54:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/helsinki-animal-law-seminar-laura-ervo-23-9-2026-27784238907df25b 2026-09-16T07:53:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/four-decades-of-discovery-at-embl-2b387676ab26e237 2026-09-16T07:48:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-a-clear-picture-of-uk-health-research-funding-5fb0da3202bb024b 2026-09-16T07:41:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinpoong-seeks-phase-3-ind-amendment-for-stroke-drug-sp-8203-7c73c2ad1ef58a01 2026-09-16T07:19:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/l-essentiel-de-la-generosite-2025-3705f63f541d6466 2026-09-16T07:14:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-is-changing-the-talent-biotech-companies-compete-to-hire-6b1fee41fba14396 2026-09-16T07:01:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/unmc-brings-ai-expertise-to-6-million-nsf-crop-resilience-project-806a9377b6c1a0e4 2026-09-16T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-than-1-500-patients-have-taken-part-in-the-clinic-prehabilitation-program-f8328961b65fbbb2 2026-09-16T06:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/decarolis-named-director-of-sponsored-programs-administration-ff1c9934438d7007 2026-09-16T06:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-healthy-living-hosts-open-house-through-sept-24-b8c9d6e946465d6c 2026-09-16T06:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chri-events-examine-advances-in-pediatric-cancer-brain-tumor-research-6b49e60b0a555f4e 2026-09-16T06:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trutakna-meets-all-endpoints-in-phase-3-iga-nephropathy-trial-final-analysis-b7255873d1b753fb 2026-09-16T06:46:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/crb-913-obesity-drug-shows-5-weight-loss-in-phase-1b-trial-3275d98d0fe2e371 2026-09-16T06:46:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/foundationone-cdx-braf-v600-braf-31eefd4b67f97474 2026-09-16T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chugai-obtains-approval-for-foundationone-cdx-cancer-genomic-profile-as-a-compan-26f849ad79ecca25 2026-09-16T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zymfentra-xcopri-projected-to-become-korea-s-1st-1-billion-blockbuster-drugs-in-1b9ece210cf9d90a 2026-09-16T06:19:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/avacta-achieves-clinical-proof-of-mechanism-for-the-next-generation-of-pre-cisio-a3abc4b621039f07 2026-09-16T06:02:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/sa-har-vgr-byggt-en-modell-for-specialistlakares-fortbildning-da64b4d7e3b0264f 2026-09-16T06:00:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/vom-spitalbett-in-den-olympia-bob-2b5738cc36b7f3c2 2026-09-16T06:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-names-new-ceo-96784a8d02bcdd18 2026-09-16T05:52:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-mnov-8-rvty-8-txg-6-tlx-9-sdgr-12-7011727fdf19ea41 2026-09-16T05:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-cafe-mondegar-licence-over-food-safety-violations-ffef6c2b8885044b 2026-09-16T05:08:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/dengiall-india-s-first-indigenous-dengue-vaccine-could-arrive-by-2027-3fcef4b37a7f1fed 2026-09-16T04:34:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-teva-starts-direct-nyse-share-trading-in-shift-fr-49f9efdcc94f4670 2026-09-16T04:24:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-pharmaceutical-tak-insider-sale-chief-transformation-o-d2af8d6500810d52 2026-09-16T04:19:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/left-ventricular-pacing-associated-cardiomyopathy-revealing-myocardial-vulnerabi-3cc98d06ff440cac 2026-09-16T03:58:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-covid-19-tracker-b43544edf907cec3 2026-09-16T03:58:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/leadless-pacemaker-implant-location-as-a-predictor-of-pacing-induced-cardiomyopa-3f898d5fd08f03a7 2026-09-16T03:52:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/alternating-va-intervals-what-is-the-mechanism-eca4f20c1cb4ac08 2026-09-16T03:46:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/fuhrendes-biotech-unternehmen-entscheidet-sich-weltweit-fur-veeva-vault-crm-8c0c10dd0f0dba7e 2026-09-16T03:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-hangzhou-biotest-biotech-co-ltd-class-a-stocks-fc0b09bee485f86c 2026-09-16T03:38:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-suspends-licences-of-mumbai-s-iconic-cafe-mondegar-3-other-eateries-6541d36f26d84549 2026-09-16T03:23:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-clinical-stage-cancer-stocks-with-pristine-balance-sheets-f682c41718245b06 2026-09-16T03:09:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmosa-biopharm-s-inhaled-drug-l606-wins-china-approval-to-launch-global-phase-ac7ff245c1936bfe 2026-09-16T03:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tenax-therapeutics-ceo-christopher-giordano-acquires-20-087-in-shares-921f29d813284c41 2026-09-16T03:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultra-processed-foods-linked-to-hidden-muscle-fat-that-may-threaten-your-knees-d87f3d7b4cce43bd 2026-09-16T03:00:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-approves-world-s-first-drug-to-treat-muscle-atrophy-in-sma-5dd33ab3b8a374af 2026-09-16T02:58:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/cambium-bio-raises-5m-to-fund-pivotal-phase-3-eye-disease-trial-025f102bc09a7c21 2026-09-16T02:52:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-guanhao-biotech-co-ltd-class-a-stocks-b31fd0b4dd031d92 2026-09-16T02:46:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-a-hidden-retinal-defense-against-vision-loss-0ba2a68267fea301 2026-09-16T02:37:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-50-anos-los-lapices-siguen-escribiendo-y-son-honoris-causa-de-la-unlp-6c7f199371003580 2026-09-16T02:14:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-50-anos-de-su-asesinato-rendimos-homenaje-a-sergio-karakachoff-45d9599f7f2a1ecc 2026-09-16T02:14:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/distinguiremos-con-el-doctorado-honoris-causa-a-los-militantes-estudiantiles-de-629241cb090f6c8e 2026-09-16T02:14:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-s-us-750-million-cancer-drug-deal-highlights-china-s-rise-as-biotech-player-019202f18c332040 2026-09-16T02:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmac-seeks-feedback-on-widening-access-to-febuxostat-for-people-with-gout-3692c364cf534524 2026-09-16T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-taps-novartis-veteran-zhang-as-ceo-58cffabf971dd26a 2026-09-16T01:55:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-midweek-pulse-xbi-loses-steam-after-hot-2026-run-here-are-the-stocks-and-7ea3ba7251b2718a 2026-09-16T01:51:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-midweek-pulse-xbi-loses-steam-after-hot-2026-run-here-are-the-stocks-and-941d72ff3dff7f07 2026-09-16T01:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/active-numeracy-welcomes-colleagues-from-tallinn-university-66ce719462cfbd5f 2026-09-16T01:41:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-reversed-biological-age-in-older-adults-in-just-4-weeks-738a0a4357926dd9 2026-09-16T01:35:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/perriello-discusses-biotech-s-future-with-local-leaders-f075c4ce96759b01 2026-09-16T01:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vera-says-phase-3-trutakna-trial-slowed-iga-nephropathy-progression-5e494faeaa8a90ad 2026-09-16T01:11:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-executive-survey-finds-emerging-biotech-ceos-increasingly-rely-on-f8dc02c36dd7a25e 2026-09-16T00:16:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-taps-novartis-veteran-zhang-as-ceo-afe8e7e7d5c3f9a6 2026-09-16T00:15:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/en-otsuka-pharmaceutical-obtains-marketing-approval-for-enofeed-liquid-for-enter-5c5b3d702f486c51 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/local-antibody-driven-response-to-anti-pd-1-blockade-c9984854653c1ff1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/establishment-and-characterization-of-primary-retinoblastoma-cell-lines-a-compre-cfac4ec02c19cc2a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predictive-and-instructive-cerebellar-encoding-of-dopamine-reward-drives-motivat-a85d22452d6058ed 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hippocampal-astrocytic-sequences-emerge-during-learning-and-memory-recall-8a32f1644356b364 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebv-reactivation-priming-of-the-peripheral-immune-system-in-multiple-sclerosis-r-cd6069644ba7186d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-specific-biological-aging-clocks-across-organs-and-omics-83fe2665d8ae7b6d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/factor-ix-padua-aav-gene-therapy-in-adolescents-with-hemophilia-b-a-phase-1-tria-51c2bc7b509e2f74 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/liquid-biopsy-for-early-detection-of-pancreatic-ductal-adenocarcinoma-6015e08250c6d78e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-pioneering-breast-cancer-drug-that-nips-resistance-in-the-bud-db40981eeca6218d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mechanisms-of-transcriptional-regulation-by-salicylic-acid-receptors-a6885e265c9723fd 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inflection-points-and-transitions-in-alzheimer-s-disease-fb32e0e5136c04b1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-without-crossovers-mimics-clonal-reproduction-in-rhynchospora-tenuis-791dc6305a28390d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rapid-patient-specific-neural-networks-for-x-ray-to-volume-registration-e12864e6d778fe8f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reimagining-research-papers-as-interactive-and-reliable-ai-agents-9751de96eb72d20f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/electroluminescent-photoresists-extending-lithographic-scaling-to-oleds-7b05f7ba1014422a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evolution-and-heterogeneity-of-lethal-metastatic-bladder-cancer-subtypes-b7ac1772dd8f10de 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/developmental-xenocortication-using-human-derived-organoids-in-mice-cbeb4bb1711cdc6f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mutational-constraints-on-rsv-f-and-its-neutralization-by-antibodies-94134cfac2f3e9e8 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/topographic-structure-and-function-of-locus-coeruleus-noradrenaline-neurons-36cc607a9bb0bd75 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeted-genomic-integration-and-rearrangement-using-prime-assembly-bb5d887a8114b8b0 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transcriptional-activation-of-plant-immunity-by-salicylic-acid-bb756098bf8d42d0 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mitochondrial-fission-factor-senses-and-governs-ferroptosis-c7d3f5a84d37b0c5 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/road-transport-of-trapped-antiprotons-6321250102761ec6 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-retinoic-acid-autoregulatory-loop-governing-prefrontal-motor-arealization-bff3419aeb23865a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-a-random-background-to-understand-ligand-optimization-beb0b7e790fb9f18 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/continuous-wave-laser-absorption-spectroscopy-of-the-thorium-229-nucleus-5ea6739e71728e0d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heterogeneous-photonic-integration-of-single-crystalline-nanomembranes-3c2e75d06c9c0e3a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/overmassive-black-holes-and-little-red-dots-naturally-form-in-simulations-8cac1eb342b3a544 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/molecular-level-observation-of-the-self-assembly-of-a-virus-like-particle-5c1f81edd02d0106 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intratumor-delivery-of-a-novel-plasmid-combination-induces-high-levels-of-metast-79bbbc4147b72673 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b9816-9-crore-consolidated-revenue-and-e2-82-b9269-0-crore-o-a2d331d374f943b7 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b9794-4-crore-consolidated-revenue-and-e2-82-b9206-5-crore-o-bb15ffb56a868eb9 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b9705-4-crore-consolidated-revenue-and-e2-82-b9151-3-crore-o-ff3ca531de5730ce 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-receives-tentative-approval-for-olaparib-tablets-from-the-united-states-fo-07ffb382cc605b33 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-receives-approval-from-central-drug-standard-control-organisation-cdsco-fo-ed6bb7eb9549f08f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-gets-approval-from-its-board-of-directors-for-increasing-it-7cb7e32ad9131eb5 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-completes-acquisition-of-additional-13-25-stake-in-adcock-i-742f3a5e16d17020 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-api-unit-in-chennai-receives-establishment-inspection-repor-8589d7753f9a150a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-announces-conclusion-of-us-fda-inspection-at-visakhapatnam-65155282926117bb 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-launches-semaglutide-generic-injection-multi-dose-vials-in-india-at-5fcd2c53d1117f58 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-announces-launch-of-pomalidomide-capsules-generic-of-pomalyst-in-the-u-s-m-215330e6ed79ad0f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-and-lupin-receive-approval-from-u-s-fda-for-eribulin-mesylate-injection-b692b9f63b741656 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/investment-of-us-14-million-in-egenesis-inc-by-natco-pharma-canada-inc-and-natco-d8d78fac298637a5 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/home-page-fd8df7af0ffe3d6c 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicare-program-medicare-appeals-adjustment-to-the-amount-in-controversy-thresh-94915c4cbe3169f1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicare-program-public-meeting-for-new-revisions-to-the-healthcare-common-proce-0dc0a936f4b41fa5 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-notice-of-closed-meetings-047468a183772e00 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/opportunity-to-co-sponsor-events-with-the-office-of-research-integrity-e16a1d817cc2ee30 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/government-owned-inventions-availability-for-licensing-8cbe3facb1cb1897 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-amended-notice-of-meeting-e0e51e61efa854a9 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-request-30-day-public-comment-request-f6ec9d29697e1d9e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/order-under-sections-362-and-365-of-the-public-health-service-act-continuing-the-6789f7d61c90e383 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-for-office-of-management-and-4931405acdc3599d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-collection-60-day-comment-request-nih-intramural-reporting-of-research-9f712e6427b6b151 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/microbiology-devices-panel-of-the-medical-devices-advisory-committee-notice-of-m-7f94431e812d15dd 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wallenbergstiftelserna-beviljar-ai-stod-till-fyra-forskargrupper-vid-ki-269b0feada1a5a2b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vill-bana-vag-for-nya-behandlingar-av-hudsjukdomar-123a8d0c9e3c54ad 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/okande-cancertrender-bland-unga-vuxna-ecaa398ef104a372 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ny-avhandling-utvecklar-statistiska-metoder-for-battre-brostcancervard-8eba6cbff21b3a27 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ki-starker-positionerna-i-arets-shanghai-amnesrankning-484868928f5a1a0b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clintec-forskare-inleder-samarbete-for-att-utveckla-nytt-naringsprotein-for-svar-059b8d3a1c617f61 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-institute-on-aging-awards-21-1m-for-cleveland-alzheimer-s-disease-resea-7c0c0070442dcafa 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cleveland-clinic-s-world-class-care-now-available-to-more-bermuda-residents-56da421e905c6660 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-finds-why-young-adults-may-develop-early-fatty-liver-disease-6ea37405cd1da8d8 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-mask-of-delirium-uncovering-a-presumed-cardioembolic-stroke-through-comprehe-ef13b4747a34df72 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mitof-an-integrated-ai-framework-for-forecasting-and-structured-reporting-in-cli-92bbf44c143caa6e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-abstract-interpreting-research-and-avoiding-clinical-traps-in-emergin-7cbbccfd1ee4c5b8 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lt-b-gt-anticoagulant-related-nephropathy-associated-with-vitamin-k-antagonists-81cedfa5bb50a11c 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/introductory-chapter-the-evolving-landscape-of-biomarkers-in-cancer-detection-an-ceb49675711378a1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-the-effect-of-aqueous-extract-of-azanza-garckeana-fruit-on-fertili-4a4cb3fe56758aa3 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-and-surgical-outcomes-of-retroperitoneal-unicentric-cas-afcd2297f84e5ad9 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-transcutaneous-electrical-acupoint-stimulation-on-colonic-spasm-durin-360fb6c6fc59753a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/figure-2-from-nikolov-d-nikolov-g-kitova-l-kitov-s-kitova-m-f-mihaylova-aa-2026-4616545417902bdb 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/review-of-aligner-materials-and-their-clinical-applications-a-literature-review-393d4d6ab5bd9c14 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/engineering-of-ohet72-nanocrystals-into-nanostructured-microparticles-for-pulmon-b1f7a2598f504136 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chia-seed-allergy-emerging-clinical-evidence-molecular-allergens-and-the-unresol-facb4541734c3403 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perioperative-hydrogen-inhalation-and-postoperative-pain-after-endoscopic-discec-722474615b8d9e0d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/equivocal-dopamine-transporter-imaging-integrating-visual-assessment-quantificat-fc6783a086ee78ab 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neural-interfaces-for-bidirectional-sensory-restoration-in-limb-prostheses-curre-5c6660fd982425f1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acute-limb-ischemia-during-pregnancy-a-case-report-and-narrative-review-of-the-l-f51dd976cf886305 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-botulinum-toxin-injection-on-masticatory-muscle-activity-in-sleep-bru-302744fb35ec2609 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-vivo-comparison-of-laser-fluorescence-near-infrared-transillumination-and-con-4347cb2b342715db 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aging-in-schizophrenia-clinical-biological-and-psychosocial-perspectives-3357f8913b674d08 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-in-pediatric-acute-lymphoblastic-leukemia-a-retrospective-coho-b454992a5aa3bec2 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transcutaneous-auricular-vagus-nerve-stimulation-targets-the-brain-gut-axis-to-t-c7ed69eab8b988b5 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mafld-is-linked-to-lower-hbv-dna-levels-in-chronic-hepatitis-b-clinical-and-tran-89e3837cbe2b6f2c 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interpretable-machine-learning-models-using-early-dynamic-clinical-features-to-p-2f08580acd61747f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-internal-validation-of-a-clinical-nomogram-for-identifying-lupus-8cf07557b9131fc2 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/roles-of-community-drug-distributors-in-health-and-development-activities-post-o-449965f56fbda972 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/engineering-the-oxidative-myocardium-ros-responsive-biomaterials-for-precision-c-f850207104621730 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-framework-of-microbial-genomic-database-for-clinical-metagenomic-pathogen-diag-45db2974831d7577 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-and-their-relationship-with-tigecycline-exposure-in-critically-fd1c7aa5123cab7e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/toward-standardized-continuous-glucose-monitoring-validation-lessons-from-the-si-d07f20738b0bc797 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/partial-clinical-remission-in-type-1-diabetes-pancreatic-cell-functional-reserve-6253910902309061 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/using-artificial-intelligence-to-build-the-radiology-clinical-trial-office-of-th-b61603ea2320a841 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-universal-biocode-framework-2-0-a-philosophical-numerical-integration-of-mul-66d5897507ba8e2e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-month-clinical-outcomes-and-exploratory-gait-changes-after-intra-articular-4792c080c51d3b2d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-short-versus-long-course-antibiotic-therapy-in-pseudomonas-8d14d9e4f063d84b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effectiveness-of-bcw-based-family-participated-digital-assisted-intervention-f1f13e21ba0263ea 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-interaction-with-inhibitors-prediction-of-exposure-of-drugs-following-drug-1b93a2c92477e7f9 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/entre-la-pluma-y-el-proceso-b456813cf4482395 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biliary-duct-invasion-in-colorectal-liver-metastases-prevalence-and-clinicopatho-6fa6ce0eaa4d7609 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acute-liver-failure-temporally-associated-with-intensive-consumption-of-plantago-b97af186d1e65650 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/machine-learning-identifies-microbiome-and-clinical-predictors-of-sustained-weig-f676385b82b8952c 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/circumferential-pulmonary-vein-isolation-cpvi-with-adjunctive-linear-ablation-vs-a47b925fa38d3406 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reproducibility-driven-clinical-translation-of-spatial-multi-omics-in-precision-82d5d75d1a1a0777 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/feasibility-and-implementation-of-a-final-year-objective-structured-clinical-exa-ee2af8b9f3f65723 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/skeletal-displacements-and-upper-airway-changes-following-tooth-borne-and-tooth-a8d9c8c27c81400d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neuroanatomical-correlates-of-transdiagnostic-clinical-phenotypes-in-major-depre-4dd2840f07cc0f2a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-partner-administered-endorphin-massage-before-cesarean-birth-on-preope-788a98637fee02dd 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-behavioral-and-symbolic-interventions-in-cocaine-use-disorder-a-pros-0c0822164a542188 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-warm-acupuncture-at-zusanli-st36-and-zhongwan-cv12-combined-with-f757e0ad9523dc71 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-aacr-cancer-progress-report-2026-i-1314c8aee227b6fc 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-year-clinical-outcomes-of-vagus-nerve-stimulation-for-higher-grade-treatment-7df4dbe3f0664ae5 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/post-procedural-angiography-based-physiological-indices-and-clinical-outcomes-af-317af6e3847c728e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-epistemological-threshold-from-corps-objet-to-nursing-theory-in-the-clinical-fb164486a8f877ca 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevalence-of-cancer-survivors-diagnosed-within-the-past-20-years-accounts-for-6-076ec70e6db1dc14 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dose-optimization-or-rescue-interpreting-week-24-disease-control-after-abrocitin-4ca84c39e4415760 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-situated-nature-of-validity-exploring-cultural-dependency-in-clinical-teache-6b769038838f3fab 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adverse-childhood-experiences-and-cognitive-functional-aging-trajectories-a-nati-5c694f37b4aaf83e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/expression-of-concern-regulation-of-the-breast-cancer-stem-cell-phenotype-by-hyp-142cf341eac8a2fd 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/factor-ix-padua-aav-gene-therapy-in-adolescents-with-hemophilia-b-a-phase-1-tria-caf86e20d800d79d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preliminary-efficacy-with-daraxonrasib-demonstrated-in-ras-mutant-nsclc-c71e341500d43920 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/structure-based-drug-design-of-quinoline-cyp8b1-inhibitors-for-the-potential-tre-456543ff4bf951da 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/measuring-ai-progress-in-drug-discovery-a-reproducible-leaderboard-for-the-tox21-b60ea7d5a1499fa1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevalence-of-metabolic-syndrome-among-adult-population-in-pakistan-a-systematic-2d50b0f09c28aafb 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bile-acid-based-therapeutics-recent-advances-in-bile-acid-conjugates-and-derivat-a1c51191c2d63fbf 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sinapic-acid-from-plant-biosynthesis-to-translational-prospects-a-critical-revie-a18d856bb31e48c9 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trends-of-laponite-clay-mineral-as-an-excipient-in-pharmaceuticals-cosmetics-and-e70dbd0ba7fac1dd 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prophylactic-and-therapeutic-effects-of-aspirin-in-cancer-2b6c5055ad36bfec 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/orthostatic-hypertension-clinical-spectrum-and-gaps-in-knowledge-94d78edfefdc7fce 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/role-of-glycosylated-small-noncoding-rnas-in-tumor-mechanism-function-and-clinic-252270806604a20b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychiatric-consultation-outcomes-in-deep-brain-stimulation-candidacy-clinical-a-8ceb7d66de01cabf 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-seawater-based-nasal-irrigation-on-nasal-congestion-in-in-2bd10283b66ded68 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-novel-presenilin-1-variant-p-scp-phe283val-scp-in-early-onset-mild-cognitive-i-afc9f2e92940044e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stripping-based-approach-for-the-recovery-of-volatile-fatty-acids-from-anaerobic-6145224ecbb3a9b7 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-circumferential-calcification-and-acquired-minimum-lumen-area-on-1-yea-9e1ca065c87ef7a8 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-guided-phenotypic-drug-repurposing-against-i-streptococc-47fae4e027c30a26 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/monitoring-changes-in-clinical-trial-primary-outcomes-using-large-language-model-7383880a066a1eac 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07823699-trial-of-device-that-is-not-approved-or-cleared-by-the-u-s-fda-b18be769e7dd385c 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07823517-llm-generated-medical-summaries-during-hospitalization-to-improve-pa-882b39bcb56522fa 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07823244-quality-of-recovery-after-primary-breast-cancer-surgery-comparing-th-260cc0f61eab388a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07823062-specialist-review-of-harm-ratings-for-clinical-responses-acronym-noh-3ff667fc25d0606f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07822685-multicenter-clinical-study-on-the-efficacy-and-esthetic-outcomes-of-df2825dda186a931 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07810010-phase-2b-study-of-a-respiratory-syncytial-virus-and-human-metapneumo-8db7a3db2904b52f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07806773-study-of-tub-040-in-participants-with-unresectable-or-metastatic-non-bf451d76c6d0d11a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07775313-base-edited-hematopoietic-stem-progenitor-cell-gene-therapy-for-trea-598ef3dcb0ccb96b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07688707-acute-effects-of-cervical-manual-therapy-on-eye-blood-flow-6444a0014219b05e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07667400-docetaxel-and-sx-682-in-recurrent-metastatic-head-and-neck-squamous-eb782075b524b62c 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07663318-a-phase-1-study-to-evaluate-the-relative-bioavailability-of-octreoti-e4a65dc45d4f3b1b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07532902-a-study-of-bms-986504-with-standard-of-care-therapy-for-people-with-3f6f510d3d3c7507 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07449962-effect-of-counselling-using-lifestyle-medicine-assessment-tool-on-hy-72760a91433e4062 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07370480-knee-osteoarthritis-and-thermal-spa-treatment-0111d73736bf1248 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07262983-evaluating-the-safety-and-tolerability-of-baricitinib-in-patients-wi-834c49c5b61fdd2a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07243171-a-phase-ib-iia-study-to-evaluate-the-safety-tolerability-pharmacokin-45b30195ca87a7b3 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07225634-a-study-of-combogesic-iv-intravenous-in-pediatric-patients-with-acut-7b86c149b77d7c29 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07080242-evaluating-bl-m14d1-in-subjects-with-locally-advanced-or-metastatic-30ee71cd4473032b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07061080-refractory-advanced-digestive-neuroendocrine-carcinomas-treated-with-00dc43390d3c06c5 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07060547-investigating-hepquant-duo-test-as-a-biomarker-in-alcohol-related-li-f927b4b6d8c5f719 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07052903-triton-cm-a-study-to-evaluate-nucresiran-in-patients-with-transthyre-d944a3ade90606be 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06927999-an-outpatient-study-of-the-efficacy-of-ars-2-in-patients-with-chroni-dc39c06a5edb889e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06904066-autologous-t-cells-transduced-with-retroviral-vectors-expressing-tcr-8a1bed717e911091 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06735664-zanubrutinib-in-combination-with-odronextamab-for-the-treatment-of-p-33485fe3d07c85a0 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06686251-evaluation-of-the-efficacy-of-diagnostic-support-algorithms-in-chest-f01aeb081e8adf32 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06606990-testing-how-the-body-responds-to-the-drug-cx-5461-pidnarulex-in-pati-b090c9b3d5c67e70 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06497556-a-study-evaluating-the-efficacy-and-safety-of-divarasib-versus-sotor-c73a6844b830f91f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06345495-high-dose-ruxolitinib-and-allogeneic-stem-cell-transplantation-in-my-642c45e95322fb42 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06345027-chimeric-antigen-receptor-treatment-targeting-cd70-seventy-bb7644971c14a29e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06233942-phase-1a-1b-first-in-human-study-of-bg-c9074-alone-and-in-combinatio-c5317bf6b5ad7cf3 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06173518-a-study-of-cd19-targeted-car-t-cell-therapy-in-pediatric-patients-wi-892481086f48db14 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06104020-effect-of-liberal-versus-restrictive-intraoperative-fluid-therapy-on-e45e5d896ef5d276 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05987241-testing-the-role-of-dna-released-from-tumor-cells-into-the-blood-in-6e15e5c490cca791 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05950581-treatment-of-skeletal-class-ii-malocclusion-with-modified-twin-block-92667869ab997e0d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05913388-gb1211-and-pembrolizumab-versus-pembrolizumab-and-placebo-in-patient-b251540f83cc4e19 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05857865-single-session-psychotherapy-for-young-kids-through-patient-engageme-363cc4111d228ea1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05763797-developing-a-culturally-relevant-supportive-care-program-for-black-p-ece8f851c645adf2 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05751668-finding-an-effective-dose-of-gm1-to-reduce-or-prevent-neuropathy-num-e8719bfacbe11f3f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05464576-tumor-staging-t-of-bladder-tumours-correlation-of-mri-and-anatomopat-ca9c339eed6a8ecb 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05440617-biorepository-in-participants-who-undergo-otc-for-gonadotoxic-therap-701d52a84cb29125 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05419024-imaging-and-biopsy-of-people-with-hiv-1-undergoing-analytic-treatmen-ba9c2ed4984d9b75 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05364606-patient-specific-talus-spacer-post-approval-study-a02f2660f852629f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05343013-tas-102-with-or-without-celecoxib-in-ctdna-defined-minimal-residual-03dbdae8ce8d08c4 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05316688-a-fluorescent-tumor-marking-agent-tozuleristide-for-imaging-oral-cav-1606a97bf1f6cd46 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04866134-a-study-of-eras-007-as-monotherapy-or-in-combination-with-eras-601-i-95f872e2ad976cd5 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04808427-pilot-study-to-investigate-magnetic-resonance-mr-image-guided-focal-b4623e9007f72207 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04760652-cognitive-behavioral-therapy-following-esketamine-for-major-depressi-4106eab7fe215ec7 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04461483-a-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-720ad15c855bc477 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04077099-a-study-of-regn5093-in-adult-patients-with-mesenchymal-epithelial-tr-9b4e20efe61d11da 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03572465-quantitative-ultrasound-techniques-for-diagnosis-of-nonalcoholic-ste-fec4f2b26065618b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02146170-tissue-procurement-and-natural-history-study-of-people-with-non-smal-bd3c1921a726f965 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01629498-image-guided-intensity-modulated-photon-or-proton-beam-radiation-the-105bb6dad105cbc6 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01568697-oral-bacteria-and-immune-system-problems-involved-in-gum-disease-per-2851c8e90bcff2a1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01498263-inherited-diseases-caregiving-and-social-networks-516e94c56e9b605f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01445483-neuropsychological-changes-in-patients-receiving-radiation-therapy-f-698e4e99ebedb3c7 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01443468-clinical-and-genetic-studies-of-li-fraumeni-syndrome-562b3d53b8340d6e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01432847-cell-collection-to-study-eye-diseases-3f7d97feaf79bb2b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaneck-pharmaceutical-etf-vs-vaneck-biotech-etf-which-fund-is-better-for-drug-in-b9bc71be1ddc8dc6 2026-09-15T23:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tom-perriello-joins-biotech-leaders-in-discussing-the-future-of-the-industry-13f2b46b03a0976a 2026-09-15T22:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recon-experts-press-fda-to-set-safety-access-standards-for-psychedelic-drugs-gsk-3665e6a8d1db5683 2026-09-15T22:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-hearing-on-psychedelic-medicine-reveals-a-field-divided-on-the-road-to-appro-66ed1628669a29ac 2026-09-15T22:11:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/21-cfr-part-820-qmsr-what-changed-and-how-to-comply-bdd37ce77b959bde 2026-09-15T21:55:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/australian-biotech-sues-grail-over-multi-cancer-blood-test-c5040893d12c96e8 2026-09-15T21:21:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychedelic-drug-trials-patient-safety-take-spotlight-at-fda-hearing-3c3aa5cc1f9daeff 2026-09-15T20:56:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/capa-management-5-elements-of-an-effective-capa-system-0ca14dd7350e28ab 2026-09-15T20:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pomerantz-law-firm-announces-the-filing-of-a-class-action-against-aardvark-thera-528a6f2157cc4e25 2026-09-15T20:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-taps-novartis-veteran-zhang-as-ceo-2e29865224852ac9 2026-09-15T20:26:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-corporation-e4e73548800141d8 2026-09-15T20:26:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-veteran-ingrid-zhang-tapped-to-lead-legend-biotech-0e9909e2fc0033ed 2026-09-15T20:04:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/sanofi-cheplapharm-form-strategic-partnership-pharmexec-251834663ca8ba0d 2026-09-15T19:48:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-bolsters-oncology-pipeline-with-750m-chimagen-tce-deal-826c82260bc41af2 2026-09-15T19:48:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/if-you-name-it-you-can-tame-it-102ad926a350c9a5 2026-09-15T19:35:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/our-biotech-etf-pick-is-on-a-roll-there-s-plenty-of-reasons-to-stay-bullish-bc9825efc83646e6 2026-09-15T19:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-ai-is-rewriting-the-rules-for-medicine-and-biotech-in-mass-2641f3cd0e60363a 2026-09-15T19:19:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/montana-s-giving-the-biotech-industry-sweeping-authority-to-sell-unapproved-drug-2190e459be361d76 2026-09-15T19:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/toward-canonical-helm-representations-for-sequence-level-peptide-registration-1daac6a9a95951c5 2026-09-15T19:02:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/ori-biotech-lands-10-year-120m-commercial-cell-therapy-manufacturing-deal-7056cd82be379659 2026-09-15T18:58:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/raising-kids-in-a-digital-world-with-less-fear-more-strategy-9c6c928fc1781741 2026-09-15T18:54:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-uconn-school-of-pharmacy-alumni-will-be-recognized-at-the-2026-uconn-schoo-1fefb87b25eb0c92 2026-09-15T18:51:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/russian-strikes-damaged-ukrainian-pharma-hub-logistic-center-steel-plant-killing-853d697821a8fef7 2026-09-15T18:50:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/oric-oric-doubles-down-on-prostate-cancer-with-phase-3-launch-f66cc21c17ead25d 2026-09-15T18:28:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-and-west-valley-city-unveil-plans-for-major-new-medical-cam-0c88cab57bef4e35 2026-09-15T18:15:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/kff-tracker-america-first-mou-bilateral-global-health-agreements-e54c4408e718605b 2026-09-15T18:12:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/drugstore-museum-hooks-visitors-with-old-timey-treats-and-pharmaceutical-history-61f4e7444ae094a1 2026-09-15T18:12:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/iq-oq-pq-explained-2026-process-validation-guide-e94487244e4749c5 2026-09-15T18:01:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/29a-convocatoria-del-fondo-regional-para-proyectos-de-cooperacion-triangular-002ec6ed68b7ec77 2026-09-15T17:55:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/lonza-to-build-new-pharmaceutical-manufacturing-facility-in-bend-49861c4b3456de31 2026-09-15T17:46:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/iso-14971-risk-management-for-medical-devices-2026-guide-219c6abcfbfaa90d 2026-09-15T17:42:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-ai-biotech-isomorphic-labs-is-not-slowing-down-exec-says-a015998a3add4c6b 2026-09-15T17:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pbe-vs-rsph-is-a-biotech-etf-or-equal-weight-healthcare-etf-the-better-choice-fo-98e58d141079b271 2026-09-15T17:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-safety-communications-9827bff184a3fa3a 2026-09-15T17:21:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/could-you-survive-the-oregon-trail-an-emergency-medicine-doctor-offers-tips-on-h-c88c6bb91a76a3f1 2026-09-15T17:17:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-trump-backs-psychedelics-research-fda-weighs-safety-and-access-standards-5288c954840a3a9a 2026-09-15T17:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trials-sellas-life-sciences-39fff20cebd8d953 2026-09-15T17:08:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-personalized-disease-prediction-and-prevention-in-chronic-inflamm-dc682383b7c99e54 2026-09-15T17:06:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-bridging-gaps-in-mental-health-support-a-comprehensive-european-s-9e9a95fdd93723af 2026-09-15T17:06:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/genfit-plans-phase-2-liver-failure-trial-after-acquiring-immunomodulator-from-in-a5b612c6084d9b58 2026-09-15T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/external-data-accelerator-your-standards-first-team-and-technology-for-conforman-d396193ebbd13297 2026-09-15T16:57:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/iso-13485-explained-medical-device-qms-requirements-2026-6706a1c61f947803 2026-09-15T16:54:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-cost-avoidance-advancing-unit-level-pharmaceutical-economics-in-health-sy-a6670ef0c8744a77 2026-09-15T16:53:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/lineberger-building-technology-base-for-better-cancer-vaccines-9117c3b12ec6706d 2026-09-15T16:47:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/pbe-vs-rsph-is-a-biotech-etf-or-equal-weight-healthcare-etf-the-better-choice-fo-8d536855447ea87f 2026-09-15T16:43:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/vera-therapeutics-vera-stock-surges-following-promising-origin3-trial-results-0dcc1dff0d8c2ccf 2026-09-15T16:37:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/must-see-museums-the-heritage-gallery-f8ae478aab63fcf2 2026-09-15T16:34:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/minnesota-healthcare-providers-detail-harm-to-patients-from-operation-metro-surg-1431dfd58da5f22f 2026-09-15T16:34:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/minnesota-private-well-owners-are-largely-on-their-own-when-it-comes-to-arsenic-592a54313504782c 2026-09-15T16:33:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-a-federal-mail-in-ballot-proposal-means-for-minnesota-voters-37e175b0fe4b7083 2026-09-15T16:33:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/cafe-mondegar-among-4-mumbai-outlets-suspended-by-fda-over-food-safety-violation-198e42aafbca49fe 2026-09-15T16:29:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/government-response-to-the-thirlwall-inquiry-ff462750db59e27b 2026-09-15T16:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jornada-en-conmemoracion-del-dia-mundial-del-alzheimer-en-la-unlp-0662c09aeb82f613 2026-09-15T16:23:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-energy-uc-irvine-never-used-47d02add849c9ba3 2026-09-15T16:21:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/government-to-act-on-thirlwall-patient-safety-recommendations-8e24371ba7eef03b 2026-09-15T16:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/skyhawk-therapeutics-announces-final-fifteen-month-results-from-phase-1-2-clinic-a77c77723be25e10 2026-09-15T16:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-tumour-host-interactions-in-liver-cancer-of-childhood-and-adults-777a915ed3a87482 2026-09-15T16:18:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-expanding-the-european-ehrxf-to-share-and-effectively-use-health-1332b9417654bb6b 2026-09-15T16:18:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-virtual-brain-twin-for-personalised-treatment-of-psychiatric-diso-c73fc5eb4b7281e6 2026-09-15T16:18:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/ich-kann-zeigen-was-ich-kann-schon-in-jungem-alter-bd19b1665f8d76d6 2026-09-15T16:04:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-queueing-science-could-fix-hub-staffing-guesswork-8b1c0f65b7491859 2026-09-15T16:01:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/bezisterim-may-help-with-some-long-covid-symptoms-drug-s-developer-reports-in-ea-dd98e1666787e33f 2026-09-15T15:54:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/waltham-biotech-cuts-nearly-half-its-workforce-after-cystic-fibrosis-drug-fails-154605cf755a25bf 2026-09-15T15:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ori-biotech-signs-10-year-120m-deal-to-automate-commercial-cell-therapy-manufact-adbe486e7d89146b 2026-09-15T15:52:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/guy-s-pharmacy-launches-medicine-collection-lockers-81967b05e661e7b2 2026-09-15T15:44:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-shot-against-four-dengue-strains-what-india-s-home-grown-dengiall-vaccine-co-1d2bfa01ec868da0 2026-09-15T15:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/convenio-de-colaboracion-con-la-defensoria-de-la-ninez-bee014f00dc8db5c 2026-09-15T15:38:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-estudiante-que-representara-al-pais-en-un-congreso-aeroespacial-visito-el-rec-6eb1e2fe926ccbe3 2026-09-15T15:38:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/constituimos-la-mesa-de-computacion-cuantica-89b47da77220d081 2026-09-15T15:37:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-entrepreneur-philip-goelet-joins-whitehead-institute-board-of-directors-73e5ecc85fa4e229 2026-09-15T15:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubc-researchers-awarded-1m-wall-fellowships-to-advance-human-and-ecosystem-healt-44c569f2963ac6a1 2026-09-15T15:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/material-de-lectura-8517301ac515699d 2026-09-15T15:28:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/concursos-nodocentes-983118a1cfff9744 2026-09-15T15:28:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/concursos-presidencia-0738a9ef10c73b04 2026-09-15T15:28:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/le-micro-de-la-maternite-un-podcast-pour-s-informer-sur-sa-grossesse-53d9972b3d11bf70 2026-09-15T15:19:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-partnership-creates-pathway-from-clarkson-college-to-unmc-pharmacy-programs-fbb78b823002db73 2026-09-15T15:08:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-accepts-curi-bio-s-letter-of-intent-into-istand-program-to-qualify-3d-neurom-00b00f0510c84820 2026-09-15T15:06:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/smelling-chocolate-helped-men-complete-more-reps-without-feeling-more-tired-d83c990ebb92dc03 2026-09-15T15:03:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-a-playbook-for-dscsa-value-beyond-compliance-eb0d87a1e73b22ed 2026-09-15T15:02:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-better-ways-of-screening-drugs-could-soon-lead-to-thousands-fewer-animal-tes-0d8c9553c4016f5c 2026-09-15T15:01:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubiquitin-marks-abnormal-glycogen-for-destruction-to-protect-the-brain-a4e2ef403604f771 2026-09-15T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-named-official-pharmaceutical-sponsor-of-the-pga-tour-and-2026-presidents-2e56b8e582b343fa 2026-09-15T14:59:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-and-biolabs-university-of-toronto-open-applications-for-abbvie-biotech-in-75f7dce44dd8df60 2026-09-15T14:58:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-advisory-panel-ukap-enquiry-form-38f5d243521e9931 2026-09-15T14:52:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/imvax-announces-additional-data-from-phase-2b-clinical-trial-of-igv-001-in-newly-d5d0f8a72497251b 2026-09-15T14:48:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-industry-wrote-montana-s-right-to-try-law-now-they-re-running-the-sh-d462381332cb2633 2026-09-15T14:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/student-entrepreneurs-vie-for-35k-shark-tank-style-f9820b04c2555df4 2026-09-15T14:41:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-primary-children-s-hospitals-once-again-ranked-among-nation-002824e58ab7f154 2026-09-15T14:41:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-haven-biotech-raises-33m-for-cancer-drug-development-73485c033219a385 2026-09-15T14:39:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-driven-envirolab-team-maps-the-heat-06daa6d460a43865 2026-09-15T14:38:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-hears-80-speakers-on-psychedelic-drug-therapy-standards-08469c1399c0a84a 2026-09-15T14:33:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-discover-a-major-brain-shift-between-ages-50-and-75-aa4a9d132a2808ca 2026-09-15T14:28:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-and-biolabs-university-of-toronto-open-applications-for-abbvie-biotech-in-4f7584c7886f13aa 2026-09-15T14:27:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/agentic-ai-trust-gap-slowing-healthcare-provider-adoption-survey-reveals-c9537e83af37e3d8 2026-09-15T14:24:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-to-acquire-potential-best-in-class-t-cell-engager-tce-for-multiple-myeloma-f-62e7d22436b47e77 2026-09-15T14:21:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/supporting-complex-phase-i-studies-through-integrated-imaging-and-specialized-as-0e0c38380763ff9c 2026-09-15T14:15:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/defining-ad-disease-flares-vs-drug-effects-a-comparative-analysis-of-phase-3-sys-9b3a6140d8d68e9f 2026-09-15T14:14:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/stakeholders-urge-fda-to-define-data-treatment-standards-as-psychedelic-drugs-ne-f1bbb0b0fd948389 2026-09-15T14:01:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/rare-disease-reform-cmc-risk-reshoring-us-trials-top-of-mind-ahead-of-pdufa-viii-a6dd2bd949ba3468 2026-09-15T14:01:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/r1-32-like-public-antibodies-acquire-tolerance-to-sars-cov-2-antigenic-drift-thr-7fa3df58a8d5fc96 2026-09-15T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/does-acute-inflammation-triggered-by-infection-promote-cancer-progression-702deb6ae40a1b0b 2026-09-15T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclic-tri-adenylate-controls-a-carf-tm-effector-in-type-ii-panoptes-anti-phage-07d85a1a86f7eeeb 2026-09-15T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/atlastin-2-mediated-endoplasmic-reticulum-membrane-tethering-is-critical-for-fla-7a3fae0ad4a441cd 2026-09-15T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/connect-s-dupixent-rival-flunks-phase-2-asthma-trial-but-biotech-sees-reasons-fo-df8ae3f97c319dcf 2026-09-15T13:55:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/obesity-drugmakers-are-testing-in-kids-as-young-as-6-15423b2c677d102a 2026-09-15T13:53:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-psychedelics-hearing-tackles-questions-about-treatments-6d105a363d636f01 2026-09-15T13:52:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/despite-3-patient-deaths-cullinan-taiho-plan-fda-filing-for-lung-cancer-pill-on-ccce6f34ab127e2a 2026-09-15T13:51:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-new-drug-trial-approvals-at-cspc-pharmaceutical-group-stock-has-changed-its-286c1b7011894676 2026-09-15T13:50:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-week-ending-11-october-2026-f8d136078761e069 2026-09-15T13:45:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-norovirus-and-rotavirus-report-week-42-report-data-to-week-41-data-up-t-c191b99be464c1cd 2026-09-15T13:45:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-flu-and-covid-19-surveillance-report-week-42-report-data-to-week-41-dat-81e64c216725e952 2026-09-15T13:45:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/encuentro-sobre-inmigracion-italiana-en-la-unlp-674fd69b0a715368 2026-09-15T13:44:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-taps-novartis-veteran-zhang-as-ceo-61814d75375f6c45 2026-09-15T13:43:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/kelun-biotech-reports-phase-iii-benefit-for-trastuzumab-botidotin-in-her2-positi-5456029ae019c373 2026-09-15T13:38:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/scholar-rock-clarifies-post-marketing-requirements-for-isembyld-after-fda-approv-af85aacc1f2d7ef7 2026-09-15T13:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-corporation-announces-ceo-changes-22b3bb122bfb973d 2026-09-15T13:20:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-overlooked-science-of-ecoa-when-good-clinical-outcome-assessments-still-prod-a1cf5235c4a8deff 2026-09-15T13:19:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-than-320-pain-professionals-attended-ensysce-s-symposium-on-complex-pain-e8c78633cfca9b32 2026-09-15T13:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-cancer-plan-for-england-d59ff0423140ac07 2026-09-15T13:08:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-340b-rebate-tracking-really-demands-from-pharmacies-1036825346f0ecd9 2026-09-15T13:06:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/acto-named-among-everest-group-s-top-50tm-pharmaceutical-technology-providers-fo-084ce903ab0026f7 2026-09-15T13:05:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-held-a-public-hearing-on-psychedelic-therapies-as-trump-s-push-to-speed-appr-bbfdc7e67a996d89 2026-09-15T13:02:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-can-focused-ultrasound-treat-tremor-and-movement-symptoms-in-parkinson-s-dis-7207a68b37946004 2026-09-15T13:02:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-americans-really-want-from-drug-ads-2bb4904fef97820f 2026-09-15T13:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-names-novartis-executive-as-ceo-504f6ae79a3fda8f 2026-09-15T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/they-had-a-plan-how-sophia-s-parents-found-care-for-rohhad-syndrome-a0e028ec4c72bb5f 2026-09-15T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-covid-19-inquiry-53a03ab2ca904c16 2026-09-15T12:56:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/scholar-rock-clarifies-post-marketing-requirements-for-isembyld-after-fda-approv-94118c4ce3f4d105 2026-09-15T12:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/has-group-announces-swissmedic-approval-of-cerbios-expanded-reduced-folates-prod-0e7a73cb46e0db15 2026-09-15T12:50:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/heilbronn-ai-virtual-networking-week-2026-dec5a1ccfcccd8e8 2026-09-15T12:48:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-taps-novartis-veteran-zhang-as-ceo-151b6723d1790a16 2026-09-15T12:42:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/co-creating-an-individual-data-return-template-a-patient-centered-approach-by-ci-8088f2b95ea81f5a 2026-09-15T12:42:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-pledges-up-to-237m-per-program-in-cns-genetic-med-collab-with-canadian-bio-4810915a9a39abc1 2026-09-15T12:42:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/heilbronn-ai-fellowship-becas-para-estancias-de-investigacion-en-inteligencia-ar-6d9a9023f63f4ac4 2026-09-15T12:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/canaccord-raises-definium-therapeutics-price-target-on-trial-results-823ad11d724e1346 2026-09-15T12:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-50-anos-de-la-noche-de-los-lapices-recuperar-la-historia-para-construir-nuevas-b16602b68dc469b8 2026-09-15T12:30:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/survey-adults-with-multiple-or-complex-health-conditions-face-significant-challe-07e5b9e1d7bf6098 2026-09-15T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-care-access-and-affordability-for-adults-with-multiple-or-complex-health-40f35f4aa2e21f66 2026-09-15T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-named-official-pharmaceutical-sponsor-of-the-pga-tour-and-2026-presidents-8c59bede56b31042 2026-09-15T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaccination-of-people-with-uncertain-or-incomplete-immunisation-2614a700ef581637 2026-09-15T12:24:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/let-s-talk-with-sorrisi-in-rosa-10-anni-insieme-a936d1bccd7f37c2 2026-09-15T12:21:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/maia-biotechnology-announces-insider-share-purchases-by-board-member-and-ceo-ami-5517cde72350edd4 2026-09-15T12:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-habilita-una-nueva-aplicacion-para-presentar-telematicamente-la-declara-ced439fd208ddf21 2026-09-15T12:09:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/compass-pathways-just-answered-the-durability-question-now-comes-the-harder-prob-91b82d6d78659f27 2026-09-15T12:08:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/nkgen-biotech-to-present-on-troculeucel-for-75400b55930fb023 2026-09-15T12:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ori-biotech-announces-10-year-120m-partnership-to-advance-automated-manufacturin-a7a8016caf9792c3 2026-09-15T12:03:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/lenders-take-over-big-biotech-projects-from-developers-amid-weak-market-0da1139c9a272cf0 2026-09-15T12:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-levanto-la-inhibicion-de-importacion-dispuesta-a-la-firma-glam-distribucio-407da0257e07bbac 2026-09-15T12:02:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-legend-biotech-nasdaq-legn-ceo-could-get-10m-a-year-in-stock-grants-83bafaed24e453a0 2026-09-15T12:01:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-ai-agents-invent-their-own-language-if-you-let-them-chat-9beb98df1bc5cd4b 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/organika-gummies-foreign-site-not-listed-on-site-licence-a84ecb8691e76e80 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-target-product-profile-where-clinical-development-meets-commercial-reality-49a27a3d5b010a47 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-appoints-ingrid-zhang-as-chief-executive-officer-72bd3e18ed2e0548 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ori-biotech-announces-10-year-120m-partnership-to-advance-automated-manufacturin-7332490dba27ec05 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/allergan-aesthetics-to-advance-scientific-dialogue-on-skin-longevity-aging-biolo-22d33810a0bd348b 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/una-leona-en-el-rectorado-vicky-granatto-graduada-ilustre-de-la-unlp-0995f5cfd227b39d 2026-09-15T11:56:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/cspc-pharmaceutical-gets-breakthrough-therapy-designation-for-lung-cancer-drug-9a2411f77c5ff047 2026-09-15T11:50:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-formulation-development-solubility-enhancement-modified-release-and-a-50a246e993c73d45 2026-09-15T11:42:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-psychedelics-hearing-focuses-on-boosting-therapeutic-innovations-while-adher-564e03b72c9d5388 2026-09-15T11:41:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-inhibio-las-actividades-productivas-de-la-firma-ripezzi-s-r-l-y-prohibio-e-d13a499acca0a29e 2026-09-15T11:40:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/biovie-announces-topline-results-from-phase-2-address-lc-trial-evaluating-bezist-7ad61d619ea60776 2026-09-15T11:37:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/thirlwall-inquiry-report-e6a6b02f944b9e08 2026-09-15T11:36:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-doubles-down-on-china-biotech-paying-up-to-750-million-for-global-rights-to-7d22f9ea6a2666d5 2026-09-15T11:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/convegno-16-09-policlinico-kids-2-0-5666d4ba8d7e3d0f 2026-09-15T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-estimated-17-20-million-u-s-adults-live-with-long-covid-biovie-reports-benefi-eae313323506dbb4 2026-09-15T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/address-by-prof-mojisola-christianah-adeyeye-at-the-49th-annual-international-co-a2a7d60bb2244405 2026-09-15T11:23:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-urged-to-strengthen-psychedelic-drug-standards-c4b252a4c0a4515c 2026-09-15T11:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ocular-therapeutixtm-announces-positive-pre-nda-meeting-with-u-s-fda-for-axpaxli-1b21a6d7086131d4 2026-09-15T11:16:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-doubles-down-on-chimagen-with-750m-multiple-myeloma-wager-9bba28a103be6682 2026-09-15T11:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/leading-biotech-selects-veeva-vault-crm-globally-10705eb8501f8596 2026-09-15T11:04:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/leading-biotech-selects-veeva-vault-crm-globally-15d9a37158cd8455 2026-09-15T11:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dompe-u-s-pays-32-million-to-resolve-co-pay-foundation-kickback-allegations-foll-a18a9b45edf7a74d 2026-09-15T11:00:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/sacking-football-managers-does-not-improve-performance-study-finds-03c01ac7a2e8e41e 2026-09-15T11:00:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-study-performed-in-the-microbiology-department-of-vall-d-hebron-university-hos-a8d24f15864f0602 2026-09-15T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ocular-therapeutixtm-announces-positive-pre-nda-meeting-with-u-s-fda-for-axpaxli-df8feae142024a4b 2026-09-15T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/debut-engineers-new-biotech-ingredient-for-hyperpigmentation-bd42adb0c0606c65 2026-09-15T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vera-kidney-drug-trutakna-shows-strong-final-results-in-phase-3-trial-df6628efe3598540 2026-09-15T10:53:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/meiji-group-to-showcase-japanese-quality-cmo-cdmo-services-and-a-global-manufact-e52ed07ed40f30ac 2026-09-15T10:49:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/stopping-gum-disease-before-it-starts-with-ai-9fb6b31196acfe4a 2026-09-15T10:46:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-trustees-announced-as-cancer-research-uk-strengthens-research-and-governance-b0e6efe05865e793 2026-09-15T10:40:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-u-s-eradicated-this-flesh-eating-parasite-now-it-s-back-0a632145778feae0 2026-09-15T10:39:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/vera-therapeutics-secures-strong-final-phase-3-data-for-kidney-drug-trutakna-36d5522ea33843a0 2026-09-15T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-tulane-is-spotting-startup-gems-inside-stacks-of-academic-research-1f9769591bca433c 2026-09-15T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-halts-development-of-experimental-obesity-drug-after-phase-1-setback-d54510d85ed65bb4 2026-09-15T10:17:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/widow-s-bay-triumphs-as-most-decorated-freshman-comedy-in-emmy-history-73c1fed3e66c3e88 2026-09-15T10:02:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/veterans-and-doctors-urged-psychedelic-therapy-safety-standards-at-fda-hearing-w-fa6fb35f2fa9db3d 2026-09-15T10:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/preorder-dci-s-new-2026-27-economic-report-on-pharmaceutical-wholesalers-and-spe-cf342a4bd277e1b1 2026-09-15T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-radiology-abdomen-publishes-debut-articles-e0267cdf86aedfca 2026-09-15T09:59:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/florrax-pharmaceutical-updates-glp-core-tablet-product-information-in-dailymed-d-d44690b1b2608954 2026-09-15T09:55:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-new-nih-research-center-on-vaccine-harms-takes-shape-9fff0ee16aaaf112 2026-09-15T09:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-clinical-research-delivery-key-performance-indicators-data-to-august-2026-1b10eeb5524e0803 2026-09-15T09:50:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/benemeat-warns-uk-eu-trade-deal-could-put-wider-biotech-ambitions-at-risk-fe6a683c0c2b29a5 2026-09-15T09:45:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/lorraine-hill-joins-industry-leaders-in-conversation-on-gender-leadership-and-th-7d42b07921023b67 2026-09-15T09:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wclc-lung-cancer-news-from-biontech-akeso-and-roche-40c82f5f181ab638 2026-09-15T09:18:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-fda-and-ema-now-accept-from-real-world-data-240492ab4fd2c3b1 2026-09-15T09:17:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/chief-medical-officer-of-precision-for-medicine-line-between-phase-1-and-2-trial-5f656497ea653dbf 2026-09-15T09:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/connecting-data-people-and-patients-how-ai-is-advancing-neuroscience-clinical-tr-fbb7dc892cca538a 2026-09-15T09:10:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/century-adds-biotech-veteran-as-cell-therapies-near-milestones-1287adafcb6350ae 2026-09-15T09:10:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/don-t-get-caught-out-by-flu-this-winter-as-nhsggc-expands-vaccine-clinics-237642de4684a825 2026-09-15T09:08:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/day-1-is-ai-in-biotech-real-growth-or-hype-24ea2945d48f00f2 2026-09-15T09:05:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-regulation-and-the-dynamic-nature-of-ai-0c1651051d68903b 2026-09-15T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-driving-simcere-pharmaceutical-group-sehk-2096-higher-today-38c1d46a98971355 2026-09-15T08:56:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-s-biotech-ai-trade-finds-real-fuel-e3b1dea7cc9273dc 2026-09-15T08:56:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulatory-round-up-15-september-2026-a7c5aa202e8d1a2b 2026-09-15T08:55:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanyang-precision-chairman-faces-breach-of-trust-embezzlement-allegations-7630c5cc0a515910 2026-09-15T08:51:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/qasim-treated-by-specialists-with-all-the-rare-blood-available-across-the-countr-cf8bbd18e6915c1a 2026-09-15T08:42:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/bloodborne-virus-testing-in-prisons-and-other-places-of-detention-19658f88bc805354 2026-09-15T08:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/leprosy-notifications-to-uk-national-surveillance-2001-to-2025-cbea52de19821e05 2026-09-15T08:30:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/fratture-costali-nuove-frontiere-chirurgiche-mininvasive-al-policlinico-di-milan-ae965af1975ddb4c 2026-09-15T08:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-interest-in-chugai-pharmaceutical-co-ltd-unsponsored-adr-otcmkts-chgcy-exp-0ad45629e5c18f34 2026-09-15T08:24:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-science-unpicking-data-diversity-and-inclusive-research-design-e2ec926d17ea3e7c 2026-09-15T08:22:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/insilico-s-co-ceo-has-big-hopes-that-fibrosis-drug-can-reverse-aging-too-05298b94b951aeb6 2026-09-15T08:18:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/deutsche-bank-upgrades-astrazeneca-stock-rating-to-hold-on-trial-results-e24cf6dc3282e01a 2026-09-15T08:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-manufacturing-company-abec-opens-north-carolina-facility-35b14667e72d9b33 2026-09-15T08:06:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/bbsrc-publishes-refreshed-edi-action-plan-for-2026-to-2028-5b9f44f6886b921c 2026-09-15T08:00:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/passaparola-28-09-02-10-h-open-week-malattie-cardiovascolari-84f3f324009bddd2 2026-09-15T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/every-electron-counts-most-detailed-protein-structure-to-date-revealed-05e3072f40e0c0d6 2026-09-15T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/yprime-guide-supply-management-critical-to-irt-trial-success-for-biotech-sponsor-ff618748e3e73b3e 2026-09-15T07:58:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/definium-s-dt120-odt-meets-primary-endpoint-in-phase-3-gad-study-ffdc87d33d747dda 2026-09-15T07:58:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-fda-just-handed-psychedelic-drug-sponsors-a-framework-now-the-hard-part-star-0df868a4710c99b2 2026-09-15T07:58:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-company-uses-biotech-to-develop-more-effective-biological-pesticides-584a7468194ba384 2026-09-15T07:53:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/esr-mourns-the-passing-of-prof-filipe-caseiro-alves-30d53a422912c304 2026-09-15T07:44:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/biohaven-advanced-bhv-7000-to-pivotal-trials-without-answering-a-question-the-fd-8ef994cf536ab4e7 2026-09-15T07:38:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-ras-inhibitors-what-comes-next-in-pancreatic-cancer-ecf1adfe3a0130a8 2026-09-15T07:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hannah-benisty-and-maximilian-stammnitz-join-ar-i-crg-mountain-genomics-talent-p-4c62b23e8d169932 2026-09-15T07:30:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-nutx-8-iova-7-atrc-cnc-con-4690179e4c18e9cd 2026-09-15T07:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-facing-fda-decision-in-october-2026-32d5468f90b77d0b 2026-09-15T07:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/belgie-op-een-kantelpunt-innovatie-en-effectieve-toegang-in-de-gezondheidszorg-94c6bad5eeed7e20 2026-09-15T07:10:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/unmc-created-digital-platform-nets-recognition-nih-grant-d95c7fa1ac47495b 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eur-and-erasmus-mc-once-again-achieved-nearly-100-open-access-in-2025-29ceeb281f399463 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-news-world-report-names-uc-davis-children-s-hospital-among-best-children-s-h-81eff130777decf6 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/remembering-ernest-e-tschannen-d11bb7fa3dc7a927 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/northern-nevada-based-cancer-care-specialists-joins-uc-davis-cancer-care-network-7f2acb3d8d3957d1 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-wildfire-smoke-exposure-grows-uc-davis-researchers-seek-answers-92f9b79dafc9784f 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/partnership-creates-pathway-from-clarkson-college-to-unmc-pharmacy-programs-63ab3960072b2c50 2026-09-15T06:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/huons-teams-with-3-biotechs-on-mrna-adc-peptide-drug-projects-e922bd96adfa7ffa 2026-09-15T06:56:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/9-22-nhk-e-cdb01965a93c2f77 2026-09-15T06:56:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/frazier-life-sciences-adds-1-1bn-to-public-biotech-fund-taking-total-commitments-ff6f44cd37484361 2026-09-15T06:56:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/forsberg-event-captured-majesty-of-whooping-cranes-d2c7373c7604ca90 2026-09-15T06:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-the-eu-biotech-act-must-deliver-practical-improvements-for-clinical-trials-i-cd6fa0b28c6148ce 2026-09-15T06:55:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/durham-outpatient-center-circle-drive-to-update-striping-c98d347bad7d3824 2026-09-15T06:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sionna-to-test-sion-451-and-sion-2222-combo-in-cf-phase-2a-trial-502cb66a8d1bb08a 2026-09-15T06:48:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinpoong-revises-phase-3-stroke-trial-plan-for-sp-8203-a8cf77fc47a9bc04 2026-09-15T06:45:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/evonik-invests-80-million-to-expand-biotech-production-in-slovakia-e5631308d237f1b5 2026-09-15T06:45:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/keeps-biopharma-s-idetrexed-wins-korean-phase-2-ind-approval-c048c54abe2e3304 2026-09-15T06:21:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-firm-boryung-to-split-off-sales-marketing-divisions-ef1110c02ba6eaa5 2026-09-15T05:49:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/purity-with-purpose-clariant-health-care-raises-the-bar-for-pharmaceutical-excip-ed1ca819e43d20f0 2026-09-15T05:28:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/gemeinsam-fur-ein-gesundes-uniklinikum-8e963b027cfbb561 2026-09-15T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-could-get-its-first-indigenous-dengue-vaccine-by-2027-icmr-dg-reveals-time-544de43e0a215d6e 2026-09-15T04:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-mochida-pharmaceutical-co-ltd-stocks-c9e7c6384cd77f6b 2026-09-15T04:13:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/esophageal-ph-monitoring-capsule-recall-medtronic-and-given-imaging-remove-esoph-d9cf1ce94eb38542 2026-09-15T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nearly-10-000-patients-reveal-what-works-best-for-knee-arthritis-pain-relief-efa56f58b8e874fb 2026-09-15T03:57:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/california-to-spend-billions-on-visionary-plan-to-boost-fish-habitat-9c70e872ffcd363a 2026-09-15T03:30:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiny-cell-antennas-may-help-explain-why-some-babies-are-born-with-heart-defects-1e6857f6c530acbd 2026-09-15T03:20:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-native-biotech-yudao-bio-raises-30m-series-c-76640c7b47244685 2026-09-15T03:07:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/plague-was-killing-entire-families-thousands-of-years-before-the-black-death-d0f81adc1c6595ac 2026-09-15T02:54:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-vs-vertex-pharmaceuticals-value-stability-vs-high-growth-biotech-investmen-cf23a82612abdb43 2026-09-15T02:47:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/openai-breakthrough-triggers-existential-crisis-in-math-845ad0abedc726d4 2026-09-15T02:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2027-5a1abac55f9bda0e 2026-09-15T02:36:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/flinders-nuclear-courses-to-power-south-australia-s-future-aukus-workforce-b519f116eb423145 2026-09-15T02:33:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-best-biotech-stocks-for-2026-and-how-to-invest-95a8df16f2907324 2026-09-15T01:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/test-seoul-biotech-startups-enter-boston-pipeline-through-labcentral-950b2083d7c96caf 2026-09-15T01:30:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/navigating-biopharma-complexity-why-long-term-partnerships-matter-39b1115d3c1f4806 2026-09-15T01:21:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/propriedade-intelectual-e-eficiencia-regulatoria-como-motores-do-bem-estar-regio-47eb0fde5a9a0cb3 2026-09-15T01:16:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-detection-biotech-lodges-patent-suit-against-rival-97957de1513c39f1 2026-09-15T01:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intellectual-property-and-regulatory-efficiency-as-drivers-of-regional-well-bein-0e91412e61ed6c95 2026-09-15T01:04:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/report-from-the-fda-s-hearing-on-psychedelic-drugs-9a4b8269165dba38 2026-09-15T01:03:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/bsr-sdic-biotech-seek-cooperation-on-ethanol-biofuels-96d7ccba31ab201d 2026-09-15T00:58:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/swiss-biotech-giant-lonza-breaks-ground-on-major-bend-expansion-6a4e618ea7fbf639 2026-09-15T00:55:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/propiedad-intelectual-y-eficiencia-regulatoria-como-motores-del-bienestar-region-636ab545130e30a3 2026-09-15T00:13:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-filed-form-6-k-8a0e637c0b3e4dbe 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-filed-form-6-k-6f021ed602180448 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-filed-form-6-k-3c1d884d0596108b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/engineering-botulinum-neurotoxin-into-anti-cancer-agents-a961c38b9f672a2a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/single-cell-transcriptomics-reveals-tgf-1-associated-mesothelial-to-mesenchymal-bb2f043a84bdc3d5 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perioperative-blood-staging-based-on-personalized-ctdna-assay-for-recurrence-pre-05a67a9381a9c860 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-hierarchical-genomic-framework-associated-with-response-to-braf-directed-thera-28c3a45aa18ad1e5 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intracranial-recordings-in-humans-reveal-differential-contributions-of-medial-an-727fada75d1c43ec 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/broadly-neutralizing-antibodies-in-adult-males-living-with-hiv-undergoing-analyt-10c7cdd6ae46e688 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-breakthrough-for-ras-driven-cancers-fb8906a37f894648 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/on-premise-medical-ai-agents-for-reliable-clinical-decision-making-5faadfdcab1519ab 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oral-kras-g12d-inhibitor-gfh375-for-previously-treated-advanced-solid-tumors-wit-f3764900861d3f6e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-versatile-nanopore-identifies-four-classes-of-analytes-simultaneously-1d1ed26f07ad5c33 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ensuring-safety-and-accountability-in-china-s-biomedical-translation-system-24d508374c9320bb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-trade-center-health-program-petition-048a-peripheral-artery-disease-findin-f6d3e799437ce4e2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-trade-center-health-program-petitions-048-and-051a-stroke-finding-of-insuf-75f442dab1d68f6e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prospective-grant-of-an-exclusive-patent-license-development-and-commercializati-f2565eb7e1fb798e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-notice-of-closed-meetings-0626beb47d66f9d1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-amended-notice-of-meeting-b8a95ad8905e26c2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-information-collection-activity-multistate-financial-institution-data-m-3021d4ff81f706b9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-cancer-institute-notice-of-closed-meeting-421eb7f1bbe8c043 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/statistical-considerations-for-the-design-of-rare-disease-clinical-investigation-ebf052b141198824 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vill-knacka-hjartats-genetiska-kod-9a93a6184f8cdb67 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/till-minne-av-jan-ake-gustafsson-1943-2026-157d552849da7002 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ny-metod-minskade-aterfall-vid-formaksflimmer-15d874ef8dcb95f0 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ny-avhandling-undersoker-hur-dna-reparation-och-amnesomsattning-paverkar-immunsv-a92b2f175e0d7a03 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ny-avhandling-kartlagger-hjartskada-vid-svar-sepsis-14e2c43b092c5994 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/johan-askling-far-stipendium-for-patientnara-forskning-a73dfde5d21fffa7 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hjarnans-blodflode-kopplas-till-trotthet-efter-covid-f64ebc22e61c93a4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-kids-shouldn-t-skip-breakfast-before-school-a3942e30a1f999d5 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cleveland-clinic-children-s-named-among-the-nation-s-best-children-s-hospitals-882b1ccab9ab1c35 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jama-8ec86eab73be8490 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/audio-highlights-august-21-2026-cdf70b6bc9b1aa3f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gestational-hypertension-has-increased-affecting-1-in-10-pregnancies-cd46702af2461f9d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-freeze-dried-plasma-product-in-the-us-91551b9c452b7fca 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1-drugs-linked-to-lower-fracture-risk-in-people-with-type-2-diabetes-ac0db8b55f56cfc2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-acetaminophen-and-naproxen-sodium-combination-drug-23f6a2ff6b0ab515 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-e-scooters-more-dangerous-than-motorcycles-and-bicycles-9309e6f9174b333c 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aap-acog-speak-out-against-executive-order-fd97f969adb97da8 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-organoid-era-0d1d74c17c3dfac6 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclospora-outbreak-reveals-gaps-in-foodborne-disease-surveillance-9c1923e37ef042aa 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-life-worth-saving-87e8ab3b696abb6d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1s-from-gut-hormone-discovery-to-a-public-health-revolution-dc098d40197dcc75 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-original-yes-66773534912b3190 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unspoken-7afae036d0f0f51f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/healing-through-catharsis-in-poetry-c1c641915b1e651e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/time-to-inpatient-management-for-boarding-emergency-department-patients-4c8a954c5150c6af 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/will-autonomous-ai-exceed-ai-aided-physicians-as-the-best-medical-care-f1019c797800d26e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-workforce-well-being-2af5f79a317fd31b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-workforce-well-being-reply-3b9c300a95d19024 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/updated-guidance-for-author-use-of-ai-in-medical-publication-bb959e0d57595750 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-era-in-the-treatment-of-metabolic-dysfunction-associated-steatotic-liver-d-bc2991c82cd3907f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetics-and-safety-comparison-of-cycloserine-capsules-and-their-generic-b2e30b35cb0877d2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-dl-3-n-butylphthalide-in-spinocerebellar-ataxia-type-3-03bffa217093407e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-influence-of-pharmacogenetics-on-the-treatment-related-outcomes-of-antidepre-66a4c7490f5ffe5e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-and-treatment-adherence-among-patients-receiving-care-for-sexu-43adcc1d39fbcea3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adolescent-centered-cannabis-messaging-in-clinical-settings-preliminary-qualitat-b8d6c3a5e7c2239f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/delays-in-malignant-neck-mass-diagnosis-missed-opportunities-in-clinical-decisio-9b3c51828bc44be9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-performance-of-clinical-examination-for-detecting-knee-effusion-impac-faed480839f597f4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/harnessing-bioinformatics-to-decode-drug-resistance-and-guide-vaccine-design-in-6de558308b79a690 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/afp-commissioner-urges-conversation-about-link-between-australians-level-of-illi-928113742fc8c7bc 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-signs-the-forgotten-art-part-3-ten-more-bedside-signs-every-clinician-s-dad7c35192128594 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-world-computer-aided-detection-for-adenoma-detection-promising-but-context-5c32ac5fe4accd6f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correlations-of-the-expression-of-akap95-cx43-cpsf5-6-scffbxl2-and-scffbxo31-in-457d4f522a00c9ed 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-decision-support-for-precolonoscopy-cancer-triage-a-rule-out-oriented-m-4254b4df21b60a7b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perceptions-of-nursing-undergraduates-regarding-their-clinical-placements-a-qual-25bbee34a69cbf71 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-factors-associated-with-anxiety-disorders-in-adults-with-childhood-hypo-f5f1bbf61b678653 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/single-bolus-sequential-triple-rule-out-ct-angiography-image-quality-and-radiati-2523fc6a940efa2a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-there-a-way-to-break-the-glass-ceiling-in-the-diagnosis-and-treatment-of-extr-6dbfbb9ae0d485db 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychometric-evaluation-of-the-romanian-quality-of-life-in-adult-cancer-survivor-e4c61b7530a11b5d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-decision-making-after-receptor-conversion-following-neoadjuvant-therapy-f9281e61f8e9684d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hematological-versus-clinical-predictors-of-tumor-grade-in-endometrial-cancer-a-89a0af042aa922cc 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pathological-complete-response-and-residual-disease-patterns-after-neoadjuvant-c-938b06a557f15426 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psoas-compartment-block-versus-medial-branch-block-for-low-back-pain-a-narrative-c097443763d57ce9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serum-bdnf-in-subacute-stroke-effects-of-a-four-week-aerobic-exercise-interventi-4795366c5aa72614 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psilocybin-and-ayahuasca-in-treatment-resistant-depression-clinical-evidence-met-a68c95b0c85d72ba 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ct-perfusion-guided-thrombolysis-in-the-extended-window-from-trial-eligibility-t-18ab636f06709701 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preliminary-clinical-and-structural-outcomes-of-a-standardized-ultrasound-guided-8cc2048e61bc5867 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/triglycerides-and-ovarian-response-in-diminished-ovarian-reserve-a-two-sample-me-719c3490b9f0ca02 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-modeling-of-small-molecule-pharmaceutical-solubility-in-324bb23bea21ac32 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reconciling-conflicting-evidence-on-stress-ulcer-prophylaxis-in-critically-ill-c-adbb7e278ab70fac 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/longitudinal-changes-in-serum-soluble-c5b-9-levels-following-immunomodulatory-th-ba34b9f9ee5c0b19 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patterns-of-scholarly-literature-use-in-health-sciences-theses-a-citation-analys-285cd602f16b2cf0 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-changing-landscape-of-sudden-cardiac-arrest-in-young-adults-a-meta-analysis-fbbda51b82965c5b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-survey-of-deep-learning-models-and-their-applications-in-text-recognition-98030a04077e78b6 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/need-assessment-of-oral-health-policy-curriculum-knowing-and-teaching-gaps-among-f665dec0108303b3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/radiographic-assessment-and-orthodontic-intervention-effects-on-orthodontically-a33f050d65702b81 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-course-and-management-of-pancreatic-pseudocyst-perforation-1451c95dbc284797 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ha-dmf-hybrid-attention-based-deep-matrix-factorization-for-drug-combination-syn-c24c4f1099f6ff20 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/latent-profiles-of-characteristics-related-to-humanistic-caring-ability-among-cl-0d8da2c3b8ec7537 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/withdrawn-mr-guided-focused-ultrasound-enhanced-liquid-biopsy-sonobiopsy-for-the-a28e33a00a204c71 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/folic-acid-and-folate-6ec44d09f02a259d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-consuming-school-meals-enriched-with-fish-powder-on-zinc-status-of-sc-bcea81312a3014e4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-delivery-oriented-solubility-enhancement-of-curcumin-in-choline-chloride-ba-7f86f7046d0bf6bf 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-simultaneous-aerobic-exercise-and-cognitive-training-in-persons-with-56b2210303292630 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cryotkr-study-protocol-for-a-monocentric-randomised-controlled-trial-assessing-c-3ae306237195969c 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-paradigm-for-treating-recurrent-platinum-resistant-ovarian-cancer-synergis-e57cce58ff1c8144 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-participation-in-breast-cancer-screening-through-a-tailored-reminder-l-af8d35afed59550e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-simvastatin-versus-calcium-hydroxide-intracanal-medications-on-postope-59c7eb81fdc92fb1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-everolimus-plus-exemestane-versus-fulvestrant-in-patients-w-c3c64b64c82bc02f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fresh-elective-single-versus-double-embryo-transfer-and-healthy-singleton-birth-d8684b6d846abf0e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-features-and-treatment-outcomes-in-erythema-elevatum-et-diutinum-a-syst-ac19a3d21703b2b7 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/erratum-to-clonal-expansion-of-alveolar-fibroblast-progeny-drives-pulmonary-fibr-44ff2f7168a840cf 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/corrigendum-to-elevated-microrna-187-causes-cardiac-endothelial-dysplasia-to-pro-4c75f672d5d76622 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/going-to-the-source-pancreatic-lymph-nodes-maintain-stem-like-cd8-t-cells-in-hum-fcc64c04b96ae8b6 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/response-by-zhao-et-al-to-letter-regarding-article-dapagliflozin-to-reduce-early-015b0a731e1227ad 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-by-xu-et-al-regarding-article-dapagliflozin-to-reduce-early-recurrence-af-0c94dd0016b3241f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/table-s5-from-crb-701-a-second-generation-nectin-4-targeted-antibody-drug-conjug-c64c84a98cc49b03 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/table-s9-from-crb-701-a-second-generation-nectin-4-targeted-antibody-drug-conjug-46b13aa809978329 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-from-molecular-and-clinical-determinants-of-targeted-therapy-treatment-in-b-d06dc5130b76a1b9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-from-investigational-clinical-trial-agents-versus-conventional-second-salva-3384c787b95169af 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s1-from-molecular-and-clinical-determinants-of-targeted-the-2e8b6f4b1a694aa3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s2-from-the-first-in-human-encit01-trial-comparing-second-v-096e4c3ff1996058 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-table-s1-from-clinical-validation-of-a-multiplex-urine-biomarker-a-7c8fdcec85ec6c1f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/egfr-mutation-subtype-and-risk-of-brain-metastases-from-non-small-cell-lung-canc-43f1c6aa42c24d86 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/music-based-interventions-in-adult-stroke-rehabilitation-a-narrative-review-of-c-44e89f5c937bfc75 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-eyes-reveal-systemic-secrets-diverse-systemic-associations-in-branch-retinal-f14042c63a7b3d2f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-integrated-approach-combining-receptor-based-ensemble-screening-and-i-in-vivo-69ead253511a7684 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-analysis-of-aluminum-oxide-nanoparticle-effects-on-camelina-sativa-pe-0f2efb614e70ad3b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antimicrobial-stewardship-in-acute-exacerbations-of-copd-a-qualitative-study-of-0a4c60baff493e28 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preclinical-pharmacokinetic-and-pharmacological-profiling-of-b339-a-novel-sarm1-502265a87702e721 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-flexible-horizon-clinical-decision-support-model-for-dementia-early-detection-313a9702ec48c9d3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/distinct-risk-profiles-of-heart-failure-and-non-heart-failure-major-adverse-card-6c2a7deeff11c8d1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/meteorological-factors-and-primary-care-consultation-patterns-in-rheumatoid-arth-4244589e5dac6fa5 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-of-symptom-map-based-education-in-the-management-of-premenstrual-s-924bc4bf234159ed 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intraocular-pressure-and-optical-coherence-tomography-parameters-in-pediatric-hy-a8a26bf8cc758a93 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transabdominal-lumbar-approach-tala-versus-retroperitoneal-approach-for-robot-as-35da7dabb4be8947 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/decoding-nano-bio-interactions-gene-regulatory-networks-in-advanced-drug-loading-f65ffa6872396158 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2n-bots-a-dual-responsive-cross-scale-synergistic-strategy-for-hierarchical-drug-39e7bb594a62e3dd 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/guided-bone-regeneration-using-titanium-mesh-and-xenogeneic-graft-alone-histolog-9eaf093f0ac6237b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prescription-drug-use-among-us-adults-4ae68c0022c8c414 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-dose-intravenous-vitamin-c-and-mortality-and-organ-dysfunction-in-severe-bu-e3878b61ca52e0c3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07821411-a-real-world-study-of-ofatumumab-in-multiple-sclerosis-patients-in-g-c3246e2c2eb31624 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07821372-a-plant-based-diet-in-the-treatment-of-coronary-microvascular-dysfun-d655ef745e9b86ec 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07820839-digital-stimulation-and-anxiety-and-sleep-quality-in-intensive-care-dfd765dc4e02acd3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07820436-interactive-robot-guided-exercise-program-for-cancer-related-fatigue-28b46cb5a6ff0c06 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07820345-development-and-evaluation-of-low-cost-non-animal-biological-simulat-a2263ed273f54b88 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819812-thiotepa-based-conditioning-for-haploidentical-hsct-in-older-patient-19834e1645f4c992 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819669-video-assisted-thoracoscopic-surgery-combined-with-radiofrequency-ab-35c734308ccb4db1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819487-a-community-health-worker-service-to-address-acute-care-utilization-b002158db6f8417b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819474-optimizing-tumor-infiltrating-lymphocyte-til-harvest-site-and-patien-7b856cffb66c1902 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07818590-the-effect-of-nanoparticle-coating-of-orthodontic-brackets-on-the-ra-45cd5b663cc584f2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07816380-a-phase-iii-study-to-evaluate-the-efficacy-and-safety-of-jyp0322-in-642a98b45b02f543 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07811219-resp-fit-a-respiratory-muscle-strength-training-intervention-for-cop-72b0a308d3f1fc5e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07794072-digital-patient-engagement-in-technology-supported-neurorehabilitati-4d24420e01be64f4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07771439-a-study-to-investigate-the-efficacy-and-safety-of-belumosudil-compar-bb9961730e105b96 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07758543-combined-effects-of-proprioceptive-neuromuscular-facilitation-pnf-an-49d5ff3b502e2814 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07748403-a-study-of-the-safety-and-efficacy-of-prime-editing-pm577-in-partici-ea321f8bd62b726d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07687160-spiro-first-a-pragmatic-primary-care-embedded-pilot-trial-of-renin-g-4a0d9b3a533c4615 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07686380-il-15-superagonist-with-or-without-vaccine-in-biochemically-recurren-cfd5e39e4ab2fd00 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07605130-efficacy-and-safety-study-of-digital-cognitive-training-and-pcsk9-in-a328d58cb1f68e10 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07573462-a-study-to-learn-about-the-safety-of-an-expanded-pneumococcal-vaccin-78503e06c71ea34d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07548034-ultrasound-guided-needle-percutaneous-electrolysis-with-therapeutic-2d98465a53615160 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07455513-a-novel-tobacco-cessation-resource-for-smokers-with-a-diagnosed-or-s-babb569f21565b13 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07424677-study-of-saroglitazar-magnesium-for-pbc-patients-with-incomplete-res-04db30873bd4378a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07399730-ravulizumab-outcomes-in-polish-patients-with-ahus-627560c9e573fc75 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07384195-a-study-to-assess-efficacy-and-safety-of-n-acetyl-ged-0507-34-levo-g-07f4a720d62cbd5b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07384052-safety-and-feasibility-of-intranasal-insulin-in-patients-with-spinal-67f5e5a3a02a354d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07223190-a-study-evaluating-subcutaneous-versus-intravenous-blinatumomab-in-n-5094280ab239ca2d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07217704-using-18f-fapi-pet-to-detect-metastatic-disease-in-patients-that-hav-6a2e440643c6f86b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07217223-spaced-transcranial-direct-current-stimulation-for-treatment-resista-a196dd6caa7e573c 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07186673-hall-technique-vs-conventional-crown-restoration-in-permanent-molars-5c65b44ea921789e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07137442-distinguishing-tics-and-functional-tics-using-clinical-neurophysiolo-e0a0f7cc00953d72 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07111065-fast-for-dm-fatty-acid-supplementation-trial-fast-for-dermatomyositi-ed2b3f59cab40468 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07076888-aerobic-exercises-and-hemodialysis-patients-3a82acc449e28cf4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06991751-a-natural-history-of-cardiometabolic-disease-among-us-bhutanese-deve-74080274b3baf1da 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06971601-diagnostic-validity-ofclinical-tests-for-infrapatellar-fat-pad-impin-6b42f1c6883002b2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06968195-autologous-car-t-cells-targeting-gpc3-rpcar01-for-the-treatment-of-a-d41a860ed00a1eb9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06909357-creation-of-an-infrastructure-to-support-delivery-of-mhealth-interve-91ee37745d2dd9cb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06901531-a-study-of-zolbetuximab-together-with-pembrolizumab-and-chemotherapy-def392f8fcb82573 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06855498-rollover-study-for-participants-previously-enrolled-in-clinical-tria-6eaab02a97d67e85 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06687603-multi-site-detection-of-barrett-s-esophagus-in-patients-without-chro-06c9322cd8de53b7 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06642649-evaluation-and-comparison-between-general-anesthesia-vs-two-types-of-9dde98cb658819cb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06615973-screening-for-social-determinants-of-health-sdoh-and-cognitive-funct-69af5e89852e6a1a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06487481-study-of-preoperative-radiation-therapy-in-participants-with-resecta-fc044139700317d0 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06357377-a-study-of-the-safety-dosing-and-delivery-of-neo100-in-patients-with-729aeb3d065dda50 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06215118-a-study-to-learn-about-the-effects-of-the-combination-of-elranatamab-7661da673166f2fd 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05854498-liposomal-irinotecan-with-tas102-and-bevacizumab-for-patients-with-m-42ae3aeaaa80f865 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05800873-evaluate-the-efficacy-safety-pharmacokinetics-and-pharmacodynamics-o-9b82b9f2b79798e1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05648500-a-research-study-to-evaluate-the-effects-of-a-new-oral-medicine-call-9fea27ee297e8372 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05646212-integrating-treatment-for-mental-disorders-in-methadone-clinics-in-u-9262aea7de481f33 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05609630-study-of-oral-upadacitinib-and-subcutaneous-intravenous-tocilizumab-cf3986ca70e378eb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05593003-trial-of-device-that-is-not-approved-or-cleared-by-the-u-s-fda-8192cb0cac23aaca 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04969315-tt-4-and-tt-10-as-single-agents-and-in-combination-in-subjects-with-47e40ceba085b186 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03602092-observational-registry-data-on-gist-patients-c42decc4fe5bee88 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03233347-doxorubicin-vinblastine-dacarbazine-brentuximab-vedotin-and-nivoluma-edfaf2b3161a17d3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02974621-cediranib-maleate-and-olaparib-compared-to-bevacizumab-in-treating-p-7e4d87d92032d636 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01920737-a-novel-pediatric-inspired-regimen-with-reduced-myelosuppressive-dru-e45ceb892be60f2a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00501800-genetic-epidemiology-of-ovarian-aging-eb1fa7f9595e246f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/government-should-increase-transparency-of-medicare-drug-rebate-not-undermine-ph-a001818b52e871a3 2026-09-14T23:43:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/lonza-invests-in-bend-with-new-spray-drying-pharmaceutical-facility-5ef61dcb2124809c 2026-09-14T23:14:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-single-dose-of-pharmaceutical-lsd-cut-anxiety-scores-five-points-below-placebo-1b96a9edbdfd9952 2026-09-14T23:00:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-holds-public-hearing-on-psychedelic-drugs-as-trump-driven-push-gathers-pace-8758d5eb9f517c42 2026-09-14T23:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-scivision-biotech-inc-stocks-389ec0e5dfc677b4 2026-09-14T22:22:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/click-e-stock-sk-biopharmaceuticals-no-adverse-reactions-in-over-1-200-clinical-6b7d899aeecf60d4 2026-09-14T22:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibody-responses-in-health-and-disease-un-encuentro-internacional-para-avanzar-04ce29e0296cd3e9 2026-09-14T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-cultural-weight-of-a-psychedelic-approval-looms-fda-hearing-focuses-on-access-3dd0f695022b3990 2026-09-14T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/convegno-21-09-fattori-di-rischio-e-differenti-scenari-nella-masld-una-sfida-quo-9e0383bb1de287ac 2026-09-14T21:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-manufacturing-exozymes-picks-curia-as-commercial-scale-manufacturing-part-8072a8f65738427c 2026-09-14T21:47:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/all-eyes-should-be-on-patient-centricity-in-clinical-research-04df9b05d4503427 2026-09-14T21:47:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/cooper-green-adds-enrollment-specialists-at-uab-st-vincent-s-birmingham-uab-st-v-50e37213c7932bab 2026-09-14T21:00:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-relationship-between-glp-1-use-and-trust-in-pharmaceutical-companies-dd4ad4ab4492d263 2026-09-14T21:00:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-community-credit-union-executive-to-lead-2026-heart-walk-and-citywide-push-3dc710a6d091f198 2026-09-14T20:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/turning-a-potent-greenhouse-gas-into-a-valuable-pharmaceutical-building-block-us-c3c09f1b357c34f0 2026-09-14T20:20:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacyte-biotech-2026-revenue-0-net-income-5-79m-eps-0-54-10-q-summary-51393d86a7f3306b 2026-09-14T20:11:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-pharmaceutical-company-upcoming-launches-and-data-readouts-signal-a-major-4dc2a9d2d1a843d6 2026-09-14T20:07:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/pmcb-10-q-filings-pharmacyte-biotech-inc-sec-10-q-565620d7f0c71385 2026-09-14T20:05:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/about-200-long-covid-patients-joined-a-drug-trial-biovie-will-discuss-results-tu-67da8678a80a17b2 2026-09-14T20:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/benitec-biopharma-releases-full-year-2026-financial-results-and-provides-operati-951019e6c4827bd3 2026-09-14T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/icecure-medical-exhibits-prosense-cryoablation-for-breast-cancer-at-eusobi-2026-ddd8fe79c74d2705 2026-09-14T19:52:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/samsung-biologics-signs-usd-262-million-manufacturing-agreement-with-european-ph-fb7c4ed0f909f1f4 2026-09-14T19:48:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-pharmaceutical-company-major-launches-and-data-readouts-drive-a-pivotal-s-717627c4307b728c 2026-09-14T19:38:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-enters-rebrand-pharmexec-2c787093e950878f 2026-09-14T19:34:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/avoiding-a-sticky-situation-how-cells-stop-messenger-rnas-from-clumping-together-744314666fbd69b8 2026-09-14T19:26:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-recalls-and-warnings-zicam-nasal-swabs-recalled-foreign-pills-found-in-trazo-5ad8aa6171d7227b 2026-09-14T19:21:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/wuxi-apptec-hires-sander-lurie-on-health-issues-b699ab16252ac6c6 2026-09-14T19:17:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/experimental-treatment-improves-blood-flow-in-ph-ild-patients-lungs-bb0b8901943710d3 2026-09-14T19:11:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/russian-tuberculosis-vaccine-enters-phase-3-trials-cd8a20823059bee8 2026-09-14T19:09:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychedelics-are-wall-street-s-next-trip-why-this-biotech-stock-is-already-up-20-52049d1cb6186539 2026-09-14T19:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/with-just-6k-left-nymox-pharmaceutical-nymxf-discloses-doubt-it-can-keep-operati-e8db46bea5f1a743 2026-09-14T19:08:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-covid-vaccine-was-a-historic-success-could-its-cancer-vaccine-be-even-1cd1b0f3582ae845 2026-09-14T18:43:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/experts-urge-fda-to-set-clear-safety-and-access-standards-for-psychedelic-drugs-b5f7831b8f22e544 2026-09-14T18:34:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotech-raises-11-3-million-in-initial-pipe-led-by-patrick-soon-shiong-2a0574d4a6e16d59 2026-09-14T18:29:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-covid-vaccine-was-a-historic-success-could-its-cancer-vaccine-be-even-1e52ab6864cf2c8e 2026-09-14T18:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-to-hold-psychedelic-drug-hearing-amid-trump-push-what-it-means-for-depres-533440f01f0e6121 2026-09-14T17:57:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-fda-hepatic-impairment-guidance-what-it-means-for-your-next-dedicated-study-304156041da363ea 2026-09-14T17:39:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-krystal-biotech-krys-cheap-on-its-cantor-conference-spotlight-0c18fece4209bc40 2026-09-14T17:38:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/btig-raises-cullinan-oncology-stock-price-target-on-trial-data-22cf64853e80f8c8 2026-09-14T17:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/owkin-highlights-ai-driven-forecasting-for-phase-3-clinical-trial-outcomes-f2af50f70696c2db 2026-09-14T17:29:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/major-updates-for-apple-s-software-platforms-are-now-available-7e168732e05224a3 2026-09-14T17:10:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/siri-ai-a-profoundly-more-capable-and-personal-assistant-is-here-f931fcd3fd7e990f 2026-09-14T17:09:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/gensci-registers-phase-i-trial-of-four-target-retinal-fusion-protein-across-thre-b4aea070a721fd83 2026-09-14T17:09:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-s-new-child-safety-features-now-available-926b88dd00a7451e 2026-09-14T17:08:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-cans-early-experimental-obesity-drug-after-high-bar-not-met-778b1d9c286a2c43 2026-09-14T16:45:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-naomi-running-strong-with-latent-autoimmune-diabetes-in-adults-9fcf72340a5b9eb4 2026-09-14T16:38:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-s-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogren-s-investors-c33dcbb7609e0cdd 2026-09-14T16:37:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-bmrn-what-is-behind-the-fresh-attention-4d40e1b350ba2828 2026-09-14T16:24:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/experts-urge-fda-to-set-clear-safety-and-access-standards-for-psychedelic-drugs-a9e99d59823fe228 2026-09-14T16:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-day-at-camp-discovery-base-at-beaumont-05644ac40d5a0317 2026-09-14T16:17:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/free-ada-family-day-at-the-louisiana-children-s-museum-e820ec776aac4f44 2026-09-14T16:09:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/lung-cancer-screening-cooperation-for-efficient-processes-and-digital-networking-fd28a98854e7f430 2026-09-14T16:05:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/promising-biotech-stocks-to-follow-today-september-14th-ef83ca4efd667b1b 2026-09-14T16:04:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-in-pharma-accelerating-development-with-microsoft-the-microsoft-cloud-blog-484d640992178bbb 2026-09-14T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-path-to-stability-at-fda-188b02c94a11daad 2026-09-14T15:56:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/divided-we-fall-new-book-explores-polarization-citizenship-and-canada-s-democrat-7782838c31c3bd75 2026-09-14T15:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/extracting-cbd-from-artisanal-practice-to-industrial-production-ccc31add2fafeeeb 2026-09-14T15:51:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/rtw-biotech-opportunities-ltd-reports-earnings-results-for-the-half-year-ended-j-da34acb47d55b873 2026-09-14T15:50:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotech-announces-initial-closing-of-up-to-22-3-mln-pipe-financing-b6b99a80672f80c4 2026-09-14T15:37:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotechnology-reports-initial-closing-of-private-financing-6a8c3eab1e9ee839 2026-09-14T15:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/no-more-nordisk-novo-s-latest-trim-is-in-its-name-ac18f90a0e95918d 2026-09-14T15:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-places-partial-clinical-hold-on-biohaven-s-epilepsy-drug-days-after-795-mill-fb310141e51e479d 2026-09-14T15:29:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/severine-technicienne-de-laboratoire-2c74bfe257c1dad0 2026-09-14T15:23:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/souraya-technicienne-de-fabrication-9d9c0b4535f10a0f 2026-09-14T15:21:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/cover-of-vaccination-evaluated-rapidly-cover-programme-2026-to-2027-quarterly-da-854a7f00c802afc8 2026-09-14T15:13:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-biotech-industry-trends-reshaping-the-healthcare-market-1fff79779a254128 2026-09-14T15:13:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/fabien-pharmacien-3a609789b2007f1e 2026-09-14T15:11:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-public-appointments-2026-to-2027-92f3e9c4047ba1dc 2026-09-14T15:10:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-haven-biotech-seeks-to-raise-150m-for-drug-development-93d25e67402257ae 2026-09-14T15:07:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/midcap-biotech-outlook-cmps-leads-on-trend-momentum-and-catalyst-timing-9644863c7fee914b 2026-09-14T15:02:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/2025-2025-bb92cb39bafb6027 2026-09-14T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/saved-by-cpr-at-15-college-freshman-leads-walk-to-build-a-nation-of-lifesavers-029ca01991841a12 2026-09-14T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubc-scientists-uncover-why-some-huntington-disease-patients-decline-years-earlie-a58ece91b665ae4b 2026-09-14T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacometric-analysis-of-givinostat-to-support-individualized-dosing-recommend-ee9f071f11247a73 2026-09-14T14:56:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/shaping-the-future-of-medicine-57c9c5f343002163 2026-09-14T14:54:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/dengue-the-green-book-chapter-d659d5bcdd75ad40 2026-09-14T14:52:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-grants-priority-review-to-zasocitinib-for-moderate-to-severe-pso-1e9daa76b6caf233 2026-09-14T14:50:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-is-rising-in-younger-adults-faster-biological-aging-may-help-explain-why-af5b408f41983ad4 2026-09-14T14:47:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotech-announces-initial-closing-of-up-to-22-3-million-pipe-financing-and-t-ca8e381455767ccd 2026-09-14T14:43:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotechnology-raises-11-3-million-in-initial-closing-of-pipe-led-by-nant-cap-920b0390e9a9b55d 2026-09-14T14:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gustave-roussy-et-the-lancet-lancent-une-serie-de-conferences-internationales-su-4e55915d5469cf26 2026-09-14T14:39:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-government-response-to-the-covid-19-inquiry-module-3-report-82255ac20476e0dc 2026-09-14T14:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-ambition-to-delivery-is-the-national-cancer-plan-properly-funded-9c09e27be00761eb 2026-09-14T14:32:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-cancer-biotech-raises-11-3-million-the-los-angeles-times-owner-joins-its-board-36c5c0123605f906 2026-09-14T14:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gotistobart-lung-cancer-drug-candidate-prolonged-lives-in-trial-8e786176d108948a 2026-09-14T14:26:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/hidden-brain-wiring-may-help-keep-the-mind-sharp-as-gray-matter-shrinks-36b53f1bb0d841b7 2026-09-14T14:23:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/definium-therapeutics-dftx-stock-soars-20-on-successful-phase-3-anxiety-trial-re-b93947691e55d7f8 2026-09-14T14:23:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevenzione-dei-tumori-testa-collo-torna-la-make-sense-campaign-9cd20a882d33d472 2026-09-14T14:20:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/stifel-cuts-olema-pharmaceuticals-price-target-on-trial-concerns-by-investing-co-aff64a0df39e3aa2 2026-09-14T14:19:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-selected-as-new-home-of-uc-global-health-institute-56cd186455bc9ef2 2026-09-14T14:17:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivek-malhotra-awarded-the-febs-theodor-bucher-lecture-and-medal-2027-5ccbb2fe92bb7765 2026-09-14T14:17:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/nifst-stakeholders-seek-evidence-based-regulation-of-low-calorie-sweeteners-85989083eb27fcb7 2026-09-14T14:12:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-appoints-robert-plenge-to-board-of-directors-b4f7261b09af2577 2026-09-14T14:09:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunocore-achieves-full-enrollment-in-phase-3-tebe-am-melanoma-study-16e530c8f0b3f5f0 2026-09-14T14:02:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/alert-carolina-sirens-test-to-be-held-sept-17-d26cf30858dae636 2026-09-14T14:02:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/rezilient3-trial-efficacy-and-safety-data-of-zipalertinib-in-egfr-exon-20-insert-781f2e368253f241 2026-09-14T14:01:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/recce-pharmaceuticals-asx-rce-phase-3-diabetic-foot-infection-trial-and-mena-lic-38124a0b87aac230 2026-09-14T13:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-a-hidden-cause-of-high-blood-pressure-that-routine-tests-can-mis-60abf91e63ce05b8 2026-09-14T13:57:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/positive-topline-results-from-phase-3-panorama-study-of-dt120-odt-in-generalized-e256990a7d983a8b 2026-09-14T13:54:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-fortalece-cooperacao-com-centro-educacional-da-china-127812ec28885465 2026-09-14T13:52:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/we-are-embl-pierre-chazelas-on-connecting-people-to-support-science-758939b5b4ff1538 2026-09-14T13:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-vrxa-insider-trading-activity-2026-249623a1453a3bf2 2026-09-14T13:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-touts-lung-cancer-data-from-two-drugs-8d677a7a22389a58 2026-09-14T13:38:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/bringing-a-high-potential-bispecific-back-from-the-brink-22fd8da9d83fa842 2026-09-14T13:32:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-growth-trust-extends-strong-performance-in-2026-d9b4635f68450caa 2026-09-14T13:32:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/sahpra-and-lesotho-strengthen-regional-collaboration-for-regulatory-excellence-45f1f401fec36a52 2026-09-14T13:23:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/cu-anschutz-scientists-discover-why-shingles-pain-can-last-after-virus-is-gone-cd4689c91381e211 2026-09-14T13:20:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-at-morgan-stanley-conference-growth-broadens-fe0c6b0b57907f44 2026-09-14T13:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/edoardo-porro-il-pioniere-dell-ostetricia-che-ha-rivoluzionato-il-parto-e-ispira-a84e601e62ba77d6 2026-09-14T13:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-great-repricing-seven-assumptions-that-no-longer-hold-f2ecd76baf8525c8 2026-09-14T13:13:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-dr-michael-c-burgess-we-need-a-new-playbook-to-guard-against-counterfe-ac7bd868d307f45e 2026-09-14T13:09:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-ratios-at-birth-in-the-uk-2019-to-2023-800293e4e71f3202 2026-09-14T13:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-inc-nasdaq-bmrn-appoints-bms-r-d-chief-robert-plenge-to-d11aa567c7551aa2 2026-09-14T13:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/skontaktuj-sie-z-nami-90650b1f2a327e6a 2026-09-14T13:03:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-cells-that-help-the-tumor-the-family-history-of-tregs-reconstructed-2b4eb336a58ed5a6 2026-09-14T13:02:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/wysokiej-jakosci-sterylne-ampu-ki-dla-przemys-u-farmaceutycznego-2b9391d5780cc4b9 2026-09-14T13:02:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/rabies-post-exposure-risk-assessment-d5bf37390bb160f1 2026-09-14T13:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/krtl-biotech-appoints-federal-controlled-substance-compliance-specialist-justin-4350832aa88145f3 2026-09-14T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dare-bioscience-announces-peer-reviewed-publication-of-phase-1-sildenafil-cream-05d0eae494a7f684 2026-09-14T12:59:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/kyle-hurysz-prepares-for-career-in-business-law-2b6b87d474bcf87d 2026-09-14T12:58:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/organon-announces-us-fda-has-accepted-for-review-a-supplemental-new-drug-applica-6c0c0422506d902f 2026-09-14T12:57:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/radio-astronomer-takes-skynet-closer-to-hearing-the-universe-769cec1e800ef6af 2026-09-14T12:55:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/electra-aims-for-342m-ipo-to-power-inflammatory-drug-s-push-through-phase-3-0240e717903fd159 2026-09-14T12:52:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-discover-strange-link-between-low-vitamin-d-and-pain-40b149eb395340fe 2026-09-14T12:52:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-small-drug-stocks-poised-to-benefit-from-a-biotech-recovery-570bf916e68b800a 2026-09-14T12:51:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/contattaci-9aceed417471446a 2026-09-14T12:47:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/ampolle-sterili-di-alta-qualita-per-l-industria-farmaceutica-4fbfcda611c6fce7 2026-09-14T12:46:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/j-j-looking-to-offload-orthopedics-unit-in-20b-deal-to-apollo-bloomberg-dc98416c34c5142a 2026-09-14T12:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-quality-sterile-ampoules-for-the-pharmaceutical-industry-ab5de1c491afce3f 2026-09-14T12:39:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/gatc-health-joins-critical-path-institute-s-new-approach-methodologies-developer-05166a46c1038966 2026-09-14T12:38:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiff-oncology-and-nerviano-medical-sciences-amend-their-2017-exclusive-licens-5715a4c53623c959 2026-09-14T12:38:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-growth-trust-plc-monthly-fact-sheet-as-at-31-august-2026-a063b8d62d709d23 2026-09-14T12:38:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/etra-ipo-news-antibody-biotech-electra-therapeutics-sets-terms-for-325-million-i-0ecc46d14794d0ab 2026-09-14T12:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/geovax-and-cepi-enter-agreement-to-utilize-cepi-centralised-laboratory-network-t-68dec5d4551f2cf9 2026-09-14T12:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ampoules-steriles-de-haute-qualite-pour-l-industrie-pharmaceutique-d098a37d66a079a7 2026-09-14T12:31:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-cancer-drug-rights-dispute-settled-by-cardiff-and-nerviano-21e0f50be19d2e22 2026-09-14T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acto-named-among-everest-group-s-top-50tm-pharmaceutical-technology-providers-fo-5184e9ed11a3026d 2026-09-14T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-nasdaq-bntx-lung-cancer-drug-extends-survival-vs-chemo-in-phase-3-c6832e849c4d7d59 2026-09-14T12:29:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/major-shift-in-biotech-manufacturing-canva-0f67a9758151f283 2026-09-14T12:28:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-research-to-improve-k-12-stem-learning-gets-funding-boost-e69bf6987ccd6e3b 2026-09-14T12:23:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/biographie-jeremie-calais-170c54ede4f814fa 2026-09-14T12:18:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/leios-therapeutics-announces-positive-end-of-phase-2-meeting-with-fda-for-10xb-1-573671facadcb78f 2026-09-14T12:17:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/pulsed-field-ablation-for-perimitral-atrial-flutter-with-involvement-of-the-vein-3053caae0965f2e5 2026-09-14T12:11:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-and-autoimmune-trials-define-legend-biotech-legn-cell-therapy-pipeline-e925d7051366c5a6 2026-09-14T12:09:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/briacell-bctx-phase-3-trial-safety-endorsement-highlights-market-s-cautious-outl-2ca36055c44df42a 2026-09-14T12:09:13.000Z weekly 0.7